• 検索結果がありません。

味噌用麹菌の酸性ホスファターゼ遺伝子に関する研究

N/A
N/A
Protected

Academic year: 2021

シェア "味噌用麹菌の酸性ホスファターゼ遺伝子に関する研究"

Copied!
80
0
0

読み込み中.... (全文を見る)

全文

(1)Title. 味噌用麹菌の酸性ホスファターゼ遺伝子に関する研究( 本文 (Fulltext) ). Author(s). 安田, 庄子. Report No.(Doctoral Degree). 博士(農学) 乙第144号. Issue Date. 2014-09-24. Type. 博士論文. Version. ETD. URL. http://hdl.handle.net/20.500.12099/50394. ※この資料の著作権は、各資料の著者・学協会・出版社等に帰属します。.

(2) ȽƘɒēà2ĨƄoYkI][†ǙĬ 1À#DîÑ.  ǹ. ÄȠư´ư´ɩĒǽ´îў  ǚ Ť Ĭ.

(3) Ʉĸ. šɫ--------------------------------------------------------------------------------------------------------1 Ʊŧ ȽƘɒēà1DĐțǝ†ǙĬƟǧƛ½ä2²ɜ   Šõ--------------------------------------------------------------------------------------------8   ŀðĢɟA6ŀðȴȵ----------------------------------------------------------------11   ŀðéŸA6ċĥ----------------------------------------------------------------------15   ɓɇ-------------------------------------------------------------------------------------------21 Ʊŧ ȽƘɒēà1DĨƄoYkI][ A †ǙĬ aphA. 2Ǿ¥. AphA 2ŠƄĿ2¤ɀ   Šõ-------------------------------------------------------------------------------------------22   ŀðĢɟA6ŀðȴȵ----------------------------------------------------------------23   ŀðéŸA6ċĥ----------------------------------------------------------------------27   ɓɇ-------------------------------------------------------------------------------------------38 Ʊŧ ȽƘɒēà2Ňɓ0ĨƄoYkI][ C †ǙĬ aphC. 2ǫǒ. AphC 2ŠƄĿ2¤ɀ   Šõ-------------------------------------------------------------------------------------------40   ŀðĢɟA6ŀðȴȵ----------------------------------------------------------------40   ŀðéŸA6ċĥ----------------------------------------------------------------------48   ɓɇ-------------------------------------------------------------------------------------------64 Ơ¶A6éɫ----------------------------------------------------------------------------------------65 ńļ-------------------------------------------------------------------------------------------------------68 ŒɒȨí-------------------------------------------------------------------------------------------------69 ´ɫȨ2Âƙ.0D´řɫȨA6Åȅȗ´řɫȨ-------------------------------------76.

(4) šɫ. ȽƘ3ǵȺ2ǙǢǔ0ȅĎljȽŵȚ-CũɊŌȽɭŽ.ǧɑ1ôġ? ǵȺ2ɟə1ç%0ljȽɟ-DȽƘ3Ğá-3&2”ŸljȽƄ(-0 ìćGơź#DÆǼƄ1,?ǂɄ. EĆƂª-ɘɒ. E,DȽƘ1. 3Źƫ1Ȕż0ɔƅȦ-DȔżJsgĨ@®ŋj]s}ɣȷȟ1Á<E, D’´ǔ13ȽƘŔ2Əň1ACH@Ƈ·Œ¼ș2yYSǑ™#D.ɀ B1. E,CIJȸĨ@nm^bǠ&2Ňɓ0ÆǼƄƅȦ-D.ċBE,. D<'òȅĵû1A*,ōDìćȏ­#0F)ȅH2ɕƃ2ĂǼ1+, ?ǂɄ. E,D B1ȽƘŔGƏň#DǵȺŵãƮ&2?2ɔƏň2¿ǘ. -əƝǔ0hx}YG?'B!Ż2ìć1Ãɐ#D.!,ïNj *,ȽƘ2ťȐɡGăŪ. E,D!'. %D.3ǵȺł£&!,Ƃª1.*,ưȫ‚ÍŸ. .-D =&ȚĿȗĺÂś ȩƅ 23 ǹ 10 ê 31 ǵťȐŃDžĔĺƱ 11 đ 1AD.=& Ƚ Ƙ 2ǒÍ3 ưǤņ!3ưǤÏ6ȪȄǠ2ĖɣGŰŁ!'?21ȪȄ Ǡ2ĖɣGŰŁ!,"àGȁɔ!'?2Gœ'?2Ȼ3ưǤGŰŁ!, "àGȁɔ!'?2ņ!3E1ȪȄǠ2ĖɣGŰŁ!'?2Gœ'?21ŵ “GĜĒ!EGȅĎ. %Ï6ŗƅ. %'?22)Ȉúãů2?21. ĝǡɣ ĝǡǡ=+Ï6ǡɣG ȢȽòɟ +7!Ł»ÕɣH7 Ǡ2ȧȼȻ3ǁŘǻŖȥÕũɊ'HȃœſȦ¤ȥĎȲMQY&2ƩEB1ɣ #DŵȚG€™ǧ". ǠGœ'?22)Ȉúãů2?2

(5) .. E,D. !. ǵȺ2ȽƘ2Ëó13ŠƒDøƯǀĕ2 ü

(6) “Gœ0ȅĎưǤŵȚ. 5!. D3 ũ

(7) ÕǴ2“ǏnYaŵȚ 1óD.ǵȺ2øȨş13Ê E,Dǀĕ13 ȽƘ

(8) 1ɣĶ!'ÿ2Êɪ30<'ǰȨŻ2Ƈ·ƍ B3ǰȨķƯ1/HCGĩɒ!'ȽƘ2A0ŵȚ*'.F*,D. 1.

(9) $E1!,?ôġ2ǵȺ2ȽƘ3ǀĕ2&E.3ƊƣÌř.ȚĿãƮɒǜư „0*,D.BǵȺ-ǬĻ1ƣBE,'?2-D ǀɅƆĈ, 1982  ǀĕ@ǞDZJXJ2ĕ-3ĖȥȧGſ-ɨ*'?21SvgYOj Rhizopus Ʀ. GƇ‰. %' ?)ē

(10) Gɘɒ#D&E1Ƭ!ǵȺ2ȽƘ-3Ű!'Ȫ ȪȽƘ. @ưȄ ȄȽƘ A6ưǤ ǤȽƘ 1ēà Aspergillus ³!á‹2Ǝŋ!,ȁɔ !' 4Bē

(11) Gē.!,ĩɒ#D.Ğư2ǫdž-D œǣȕŠ, 1987 㬠 "•. Aspergillus oryzae ÜÔ¦Šµ–µìɒ]¤Ü`~®+3#. ’Ü`~®’Ü`~®9R?ME>H4?>µó l'00-!~ ®"ã¬!Ò~™¥ ˜îæf2_ƊēąǓ2ýȪȽƘ@ȄȽƘ2ūĒ3 ȪēȄē1Ű!'ưǤ.“ſGœǤȽƘ2ūĒ3ǤēY]]+Ȧ¤Â Ŀ-D'>“ſ2=Gœ,ƁêƁǹŗƅ#D.1AC ñȽƘ

(12) .ù4 EDƇ2ȽƘƊƣ. EDƊēǀA6ŗƅǀ13ȽƘɒēà A. oryzae !&. òɟ@Ɗƣôū2ǩâ1ɍɖ#Dƭ“ƄǶĨà Tetragenococcus halophila @ƭ“Ƅ ĎȲ Zygosaccharomyces rouxiiCandida versatilis 0/2ɑ0ȓƇȥȤĒǔ1ģ ɒ!űƣŞǫɌ2ȽƘ2Ƚ@ȢďȽȝɐ. EDȽƘ2ȚĿGȗ#Ņǝ13 Ƚ. ďCŴ

(13) ÔBEDűƣŞ1A*,3ȽƘ2 ȽďCŴ

(14) 2ăŪGɄǔ .!,ŋē2l{}b@ǫǒ2ǶĨà@ĎȲGǖœ#D0/2Ɓ2ąȞG!, D ôġǵȺ13Ɓȕǹ?2øɥĪG?+ŋēuOȤƁƨġ!NJǹ1F' Cŏœ¦ɠ!,'ēàà¹V{SWw}2ǀBȽƘ2ŋɣ@űƣŞ2ƊƣŮ ë1ĒF%,ēàȶĬGl{}b!ŋē.!,×Ò!,DŋēuO2ɥĪG Ʒ*,.Å1ľLJķƯ1Ō@ȽƘũɊƊƣ1 ē

(15) GȌȂ#D ?@!–

(16) .!,·ɉ!,' ǮɠòőŎ, 1987 ȍB3ɋɠ0ē1JzOyƄ2Ƀ© Ň1 ǐ GŶCD.-Ʃ26@ĦàGǿŢ! B1ēàȶĬ2ƭÎƄGăŪ %D.ǫŊÌřG·ɒ!,ɋɠ0ē2ŋGƇħ!,'.ċBED&2ý. 2.

(17) ɀĹķƯ1ºǕȁƾGɒ'ēà2ƸɚŜƀȁɔȵ¨¬BǨǷ. EŜƀȁɔ. !,ǪBE'ēàȶĬGl{}b!' ŋē

(18) Ō@ȽƘũɊ0/2űƣ1ĩɒ EDA10*'. ȽƘɒēà1ɓÐ. ED EDŠȋǔ0ƄĿ.!,3ɮȊųƥǝƥɯm|`J. [ÛɰƧƊē1DǎȢ2'>ǀɂƺɂ-Dɱē2ďCɠ0 /ÔBEDǙǢǔ0ȽƘ2Ɗȵ+<CɃ—Gɒ'ǕƖűƣ-3ē2ȚĿ 3ĩɒ#Dēà2 AC?ąū1DƊēƞģŮë2 1ưŽÜ. E,. '!!áƯǔƐȒGǨǷ!'ąū-3ƊēŮë2ƃþDǓǝǼ.0* ''>ēà2¦ɠȽƘ2ȚĿăŪ1ȉ. E@#0*'&-űƣuO. -31960 ǹęBĻƖȫ„@݃ǭƖȫ„ ɈĠUV Ǡ 1ACɋɠēà2‰ŋ ƔȆGƉɢǔ1Č*,'!!2A0‰ŋƔȆȴȵ13&2Ǒ²ɛ@ ƔȆ¹2Ș›ȴȵ²ɜ0/ĚDz0ǘƪ'>ēà2Ą<!ƄĿ2=G¦ɠȝ ɐ#D.3ijDz2Ý-D21 ƂÈ1ǷCƇȿž´2źȯ3ǃ!ēà A. oryzae 2 Ƈȿ2Ɛåž

(19) -DƗUgtȀɦ Aspergillus nidulansAspergillus fumigatus ʐ. 2005 ǹ1èǒ. E' Machida et al., 2005 A. oryzae 2Ugt¤Ƌ13\. xruȦɚó-ɅƇ¹1á.. EDŌɣƠĒîÑŞ2Ȯƨ¹ RIB40 ¹ĩɒ. E'&2ý Aspergillus nigerAspergillus flavusAspergillus sojae Sato et al., 2011. ‘ Aspergillus Ʀİůà2ƗUgtȀɦèǒ. E'&2éŸE<-ɀ². -0*'ŕɓ0ƽïŷ'1ǪBE'ɤ4E<-ēà A. oryzae 2m|`J [1À!,3ɇ 20 ŋɣƽBE,'UgtŪ13 126 ?2m|`J[ɑ †ǙĬƨġ!,' Machida et al., 2005 <' Tominaga B3 A. oryzae RIB40 g 2JkxaQW}ƇĒƅ†ǙĬov|TSxY] 46 kb GS|d}T!&2ǀ 2†ǙĬ2Šȡçɗ!,D1ACJkxaQW}GƇħ-0. Ɨ- D. Gĺ!' UgtŪ1Ʃ2JS`Kl0JkxaQW}ƇĒƅ†ǙĬo v|TSxY]Ȁɦ0

(20) .ĺ. 3. EƗƄ2ěÓACɀ²10*'.

(21) Tominaga et al., 2006 &!,:;ǧķ1ēà2†ǙĬƞģÌř2)E<ȑŬ1Ăɛ2~*'†ǙĬ]U_`K}TÌřưăŪ!' Ũğ3Ʊŧ -Ś9D. 2A1ǽ´‡´‘Ƈ´Ǡ1,ŕɓ0 Aspergillus Ʀİůà 2Ugtŭȳā«. Eēà2†ǙĬƞģÌřăŪ!'.3ǵȺ2űƣħÝ. 1.*,Ɗƣm|ZY2³ŷ@ŷ'0ìćÆǼƄGȝɐ!'ŷƊȚ«ȅGČŪư0ƕź-D.ċBED ǵȺ-3áǹťȐŃ2ɬĄȫš@ɘȭƄǍÐ2ŽÜGōñȽƘ2ĭū3Ŗţ !±ĨäljȽɟGǖœ!'ljȽȽƘ (!ǷCȽƘœąȚ 2ĭū¯ư!,D (!ǷCȽƘœąȚ13Ň.!, 5' ypeS{N^bcayLt#0F)¸Ƒ2 ĮȽŇƅȦ 5’-IMP A6njƴ2ĮȽŇƅȦ 5’-GMP 2cayLt“ Fig. I-1 ǖœ E,CEBñȽƘ1Á<EDTz]s}Ĩ.Ùljǔ1ǥ, Ƚ

(22) Gæǔ 1ăŪ. %D(!ǷCȽƘœąȚ2Ɗƣ1,3ƇȽƘGǎŬ 85°C15 ȦƟ. ǟ2œǸŝəGČȽƘǀ1Á<ED(!ƅȦȦ¤ĎƚoYkI][GȜ·š #DȔɓD Oike et al., 1984 2ИœǸąǓ13ưÉɁ0œǸƐȒǺɟȐ A6ŻëȐȔɓ-D'>(!ǷCȽƘœąȚGƊƣ-DuO3ŠǒÉ Ɂ€Ū2uO1öǒ. E,D!!ȽƘ3ôġ?ƾˆŴ2ÛljȽɟ-. Cƾˆ2ţÉɁuO2ƊȚ1?ěÛŻÇD!'*,ИœǸŝə GȔɓ.!0ŷ'0ljȽɟƊƣÌřG«ȅ#E4ƾˆ2űƣuO2ǫŴD ƾˆŵĢ«ȅ1čí-ťȐŃ2ƔƳı?Ć*,ȷ0ȱB!1čí-D< 'ôů2(!ǷCȽƘœąȚ2ƊƣąǓ1,?И2œǸąǓŦɝ-E 4Ǜɢ@Ǻɟ2ĩɒɡɕƃ1čí-D.Ø1œǸ1ADƊȚ2ɧšȹį-D '>ȚĿăŪ1Ɇɜ+.ċBED ñȽƘɍɖ2œſȦ¤Ďƚ2ŠŋĨƄoYkI][ Acid phosphataseAph. 3 ȽƘ1ǖœ. ED 5' ypeS{N^bGƶy}Ĩš!,ĮȽ20eS{N. WbGƇƅ#DŇɓ0Ȧ¤Ďƚ-D.ċBED Fig. I-2Oike et al., 1984 ȽƘ. 4.

(23) B. A. 5'-IMP2Na. Sodium Phytate. 5'-GMP2Na. Fig. I-1. Chemical structures of (A) sodium phytate and (B) disodium 5’-nucleotides supplemented in miso products as umami flavor enhancers. The illustrations were quoted from Japan Chemical Substance Dictionary Web service.. Fig. I-2. A hypothetical primary pathway for degradation of 5’-IMP (5’-nucleotides) added to unheated miso.. 5.

(24) 2űƣ¡Ǔ13ɑ0ȓƇȥÀɐ!,D'>ȤƁ2ȓƇȥɍɖ2ƪŋɣ2Ďƚ Á<ED!!ŪŚ!'A1ñȽƘǀ1Á<EDœſȦ¤Ďƚ2ƪ3ȽƘ ē1ɍɖ#D'>&2ưȡȦ3ȽƘɒēà A. oryzae 1ɍɖ#D.ċBED& -ȺîÑ-3ĨƄoYkI][·Ƅ2ǑñȽƘ2ƊƣGŀô#D'>1ȽƘ ē1,ĨƄoYkI][·Ƅ2Þ>,Ǒ A. oryzae GȦĬƇȥ´ǔʼnȵ1A C‰ŋ#D.GɄȖ.!' y}3#9,2Ƈȥ2Ȕżñƚ-CƇƫǯ-3Ň1 DNA @ RNA 0/2±Ĩ ATPADP 0/2MfzRDŽƢƫƌnjǦȥ2ė°ƅȦ-Dy}ĨOzWLt. ã-ƨġ!,D&!,y}Ĩ3MfzR2Ưń@ğȶWTcz2ŭȳǙ Ƶ0/ɑ0Ƈƫȉ•1Àɐ!,D!'*,y}ĨGƫ¬BňCĘH-ɘ ɒ#DÆĊ3Ƈȿ1.*,Ȕż-DȽƘɒē1,3ēà A. oryzae 3ȪȄ ưǤ.*'ŲȥŋĬGɔó.!,D'>ŲȥŋĬ2Ňɓ0y}ĨDŽƿãƮDkK^}Ĩ@&2Ʃ2y}ĨMY`zGȦ¤!,y}ĨGňCĘH-D.ċ BEDA. oryzae ȦȎ#DĨƄoYkI][A6ĨƄoYkI][2Šŋ -DkK][1À!,3E<-1+2îÑȳĔ. E,D. Fujishima et al., 1964; Wang et al., 1980; Oike et al., 1984; Shimizu., 1993; Fujita et al., 2003a, 2003b kK][3kK^}ĨGĂɛǔ1œſȦ¤!y}ĨGɎɚ#D İůàɍɖ2kK][3ÂĿǫ„ƄǑ·Ƅ2Ƥǒ1ɒBEDixda|y }Ĩ PNPP GÂĿ.!'ūĒ1?ƶy}Ĩš·ƄGĺ# Mitchell et al., 1997; Wyss et al., 1999b A. oryzae RIB40 ¹ɍɖ2kK][†ǙĬħȥ3ƉƊ ȡɀB1. EƄĿ2Š. E,D Uchida et al., 2006 kK][€¬2ĨƄoYkI][. 1+,3Ʃ2İůà Aspergillus niger MacRae et al., 1988 @ Penicillium chrysogenum Hass et al., 1992 ɍɖ2?21ƽïC¾Úǀ1y}Ĩȷȟ0ūĒ13&2 ĎƚƇħ †ǙĬȅô ɕƃ. ED.F*,D€Ū2A1ēà A.. oryzae ɍɖ2ĨƄoYkI][1À!,3Šȡ¤ɀ. 6. E,DưȡȦ3Ȝɀ.

(25) 2<<-D<'¤ɀ. E'Ďƚ1À!,? 5' ypeS{N^b1Ƭ#Dƶy. }Ĩš·Ƅ1+,3:.H/lj9BE,0 A. oryzae 1,3ãĿǗ½ȵ†ǙĬǾ¥ȵ@†ǙĬĤŢȵA6{q] ɏdžǙĬ2ǨǷȵ.*'ȦĬƇȥ´ǔʼnȵDǓǝ²ɜ!,C¢?E <-1ũɊēàŀɒ¹1,Đțǝ†ǙĬƟǧƛ½äG«ȅ!,DƱŧ3ȽƘɒ2ēàŀɒ¹1DĨƄoYkI][ǑƇħ¹2ȦĬ‰ŋGČ'> 1¹Ľ£łjN_SB×ɐGō'ȽƘɒēà A. oryzae KBN630 ¹Gɒ,Ă ɛǔ0Ɵǧƛ½ä2«ȅGĴ='#0F)ƜȴăƄ†ǙĬrO-D pyrG †ǙĬA6ȑƟǧȼƻéĒŐȣä2Ċƅ‹Ĭ Ku70 ]}iSĿGVb#D ku70 † ǙĬ2dzŕǾ¥¹G A. oryzae KBN630 ¹BňǪ!'Ʊŧ-3Ʊŧ-«ȅ! 'ȽƘɒēà A. oryzae KBN630 ¹2ĐțǝƟǧƛ½äG·ɒ!,A. oryzae RIB40 ¹ɍɖ2kK][†ǙĬG aphA †ǙĬ.ȿȾ!,Ǿ¥!ǀÖƾˆǫħ2ǤȽƘ ɒ2ȽƘßē Ǥē GģƊ!ĨƄoYkI][·Ƅ2ȫšGƤǒ!'<' A. oryzae 1, aphA †ǙĬGĐȅô. %ƉƊ!' AphA ]}iSĿ1+,. 5' ypeS{N^b1Ƭ#DÂĿǫ„Ƅ@ pH˜ǝ1À#DŠƄĿG¤Ƌ!'Ʊ ŧ-3Ǥēǀ2Ňɓ0 5’-IMP ƶy}Ĩš·ƄGƹĨƄoYkI][GɀB 1#D'>17 ÷2ĀȰ2 aph †ǙĬǾ¥¹GģŘ!Ǥēǀ2ĎƚƇħƄGĴ ð!'&2éŸaphC †ǙĬ&ȽƘɒēà A. oryzae KBN630 ¹2Ǥēǀ2 ĨƄoYkI][·ƄA6 5’-IMP ƶy}Ĩš·Ƅ2ɞ·Ƅ1,Ňɓ0Ɇµ GŸ'#.ȇɀ!'&-A. oryzae 1, AphC ]}iSĿGȦȎƇħ %ƉƊĎƚ2ŠƄĿGɀB1!AphC 2 5' ypeS{N^bȦ¤82ÀɐGċ ĥ!'. 7.

(26) Ʊŧ ȽƘɒēà1DĐțǝ†ǙĬƟǧƛ½ä2²ɜ   Šõ 㬧² 

(27) q A. oryzae éï!~®_æf2`å/"ã¬§× !גyž+㬧²!zÂbª æñn·0/ A. oryzae. 

(28) "0'. 

(29) !qg 

(30) t’ÅiàYNjÐaà+YNj‰›à,$SK? ê€YNj!ËÎà

(31) m­ÃYNj°ˆàeñ0

(32) /Yu et al., 2004 A. oryzae 2†ǙĬƞģ13<$ēàğȶǯ1¬ɖ DNA GǨǷ#D'>2ãĿǗ½ äG²ɜ#D.Ȕɓ-Dēà3ƪ±-D'>ɔɓÐƄȫ„¹GȦɚ#D .Dz!<'ēà3ĉƇȥĿ0/2ƪ2ɈĠ1ƭƄGĺ#'>ưLjà@ ĎȲ2A1ɈĠƭƄ†ǙĬGɌƄƔƳrO.!,ɘɒ#D.Řɖ0& 2A0ǀ-?ēà2ɋƄrO.!,ɘɒǼ0†ǙĬ+ȳĔ D Table 1-1 áǹ&2ɌɒƄ1ACƈH1ĩɒ. E,. E,D2 pyrG †ǙĬ. rO-DpyrG †ǙĬ3qX`KlZ{SWw}.fP`KlZ{SWw} 2ɞƜȴăƄ2Z{SWw}rO.!,ɘɒ-D'>ɩƧǔ†ǙĬǾ¥#0 Table 1-1. Selective marker genes used for Aspergillus oryzae transformation Gene name. Encoded protein. Phenotype Complementation of arginine. argB. Ornithine carbamoyltransferase auxotrophy. pyrG. Orotidine-5'-phosphate decarboxylase. Complementation of uracil auxotrophy. niaD. Nitrate reductase. Assimilation of nitrate. amdS. Acetamidase. Assimilation of acetamide. Sulfate adenylyltransferase (ATP). Assimilation of sulfate. Thiazole biosynthetic enzyme. Resistance to pyrithiamine. Phosphoribosylaminoimidazole-. Complementation of adenine. succinocarboxamidesynthase. auxotrophy. sC prtA adeA. 8.

(33) F) YNjL6S=7Oà 

(34) ¸0æf2_ A. oryzae 2†ǙĬƞģ13ãĿǗ½ä2²ɜ2:1?ŕɓ0 Ʋ*'&E 3†ǙĬ]U_`K}TĂɛ2Ǒ. -Dɤ4ũɊēà A. oryzae KBN616 g. ! pyrG †ǙĬrO1ADãĿǗ½ä- amyR YNjÐa2Ž(v_†ǙĬ] U_`K}TĂɛ3 4.5% t’Åig 200 g¾ 9 g Kitamoto et al., 2006 rA. oryzae RIB40 g+ KBN616 g 

(35) YNjL6S=7Oà,$ ØÈ±Ê¯iueñ0 Takahashi et al., 2006 b; Kitamoto and Yasuda, 2008; Mizutani et al., 2008 £d¦Û!©¡¶"͘„¨ºØÓ p/£d¦Û"h «©¡¶2X/) ͘„¨º2Ĩ —Ù/o{2

(36) /YNj° ˆ!jÆ"!͘„¨º!—ِ cï DNA ©¡¶ ¯ƒ'0/|-0/ ͘„¨º—Ùo{ "±Ê¯i—ÙuÕ±Êâ¹v€—Ùu! –õ´‡

(37) /Kanaar et al., 1998Fig.1-1~Ý Saccharomyces cerevisiae "• ±Ê¯i— Ùu ,.͘„¨º—Ù}10/)cï DNA "©¡¶!±ÊôZ%¯(ƒ'0 /ØÈ

(38) [߁q!Œ q"• Õ±Êâ¹v€—Ùu ,.͘„¨ º—Ù}10/)cï DNA "©¡¶ž!QU@NV¼ ¯ƒ'0/ØÈ YNjÐaxð"՟ Á

(39) Õ±Ê⹗Ùu" DNA W´sITB5U7E> ¢ÑPFAC(DNAPkc)KU70-KU80 JBT@5LDNA LIG4-XRCC4 ڀ¶kë 

(40) /Walker et al., 2001; Critchlow and Jackson et al., 19980-!?U G8’2;D/YNj![2Ða/ ,.Õ±Êâ¹v€—Ùu2”º/ ^Ï .±Ê¯i—Ùu ,/YNj?:AB4U9xð2¿žœ/ šï/“†. Neurospora crassa " ku70 YNjÐa ,.YNjÐaxð. 100% žœNinomiya et al., 2004A. fumigatus " ku80 YNjÐa ,.YNjРaxð 80% žœFerreina et al., 2004ނ0

(41) /'A. oryzae. 

(42). * RIB40 g" ku70 YNjÐa ,.YNjÐaxðç 60% žœTakahashi et. 9.

(43) Fig. 1-1. Intergation machinery of exogenous DNA into chromosome.. al., 2006bèq KBN616 g" ku70 YNjÐa ,.YNjÐaxðç 80% žœKitamoto and Yasuda, 2008 ' ligD YNj!Ða , A. oryzae RIB40 gYNjÐaxð 100% žœMizutani et al., 2008!,  A. oryzae 

(44) xð!ò

(45) YNjÐa<=BNeñ, +!ä»!YNj!oÏ+ÌÀ2 Ö\/^Ïw/ã¬í! A. oryzae “íqg 

(46) " !, xðñʯiu2{½öނ0

(47) 

(48)  &-Ʊŧ"ȽƘɒēà A. oryzae KBN630 ¹1DĐțǝ†ǙĬƟǧƛ½ ä2«ȅGĴ='ƜȴăƔƳƄ2†ǙĬrO-D pyrG †ǙĬ2ãĿǗ½ ȵGɘɒ#D'>1ī>1 A. oryzae KBN630 ¹2ƓŴƫ DNA B pyrG †ǙĬG ĤŢ!'ĸ1ǨǷ#D DNA ƼȬ2Ɵǧƛ½ĂɛGơư. %D'>1ȑƟǧ. ȼƻéĒŐȣä2Ċƅ‹Ĭ Ku70 ]}iSĿGVb#D ku70 †ǙĬGpyrG †Ǚ ĬĤŢȫ„¹2ƓŴƫ DNA BĤŢ!'. 10.

(49)

(50)  Ï­ÁŘ60Ï­Ňň.

(51)  ÇŐ£• •ÍŽÑcEZI7Łè=Õ"ŊûŐ¹£• A. oryzae KBN630 •= pyrG ~ğ È~ğÈÃߕ-Łŕ ku70 ~ğÈÃߕ-Łŕ60øéĊ DNA -ęô,Ő" Escherichia coli DH5 α =Ô- DNA Ēń-Ix_yJ,ÇŐ".

(52)

(53)  ıē60ıŒåª A. oryzae KBN630 •*. -Įó•-¯ĊıŒ,.Czapek-DoxCD ıē3.0%. glucose0.3% NaNO30.1% K2HPO40.05% KCl0.005% MgSO4.7H2O0.001% FeSO4 7H2O , 1.5% Agar =ĜŠ"5-=ÇŐ"đMx_ˆ,.7, 0.25% Triton-X100 60 1.0% Trace element0.014% CaCl20.0039% MnCl2.4H2O0.01% ZnSO40.0005% CuCl2. 2H2O0.00005% Na2MoO4.2H2O0.000015% CoCl2.6H2O0.01% FeCl3 0.0372% citric acid =ĜŠ(ÇŐ"A. oryzae pyrG YNj¨ć•-lQ[ @fSwIPsy,.㝗ěıē, 0.1% 5-fluoroorotic acid5-FOA * 0.15% uridine 60 0.07% uracil =ĜŠ"5-=ÇŐ"A. oryzae -„ĊıŒ,.J vMRluig\yıēGP ıē 2% glucose1% polypeptone0.5% KH2PO4 0.5% KCl0.1% NaNO30.05% MgSO4.7H2O =ÇŐ"?ntT”ð-¬Ú, .CD ½à—ěıēĖ-JvMR=RWY,Ĕ˜"RWY—ěıē=ÇŐ "A. oryzae -ıŒ. 30°C ,(µ„ĊıŒË.Ō 160 rpm -ĝÍë*= µ%" E.coli -ıŒ,. 2xYT ıē1.6% Bacto tryptone1.0% Bacto yeast extract0.5% NaCl =Ő ķő,†(ĬĢ 50μg/mL - ampicillin sodium =ĜНĊıŒË,. 1.5% Agar =ĜŠ"ıŒ. 37°C ,(µ%".

(54)  A. oryzae -¦Îĝ˜. 11.

(55) A. oryzae = MP ıē2.0% malt extract0.1% Bacto peptone2.0% glucosepH6.0 Ė)pyrG YNj¨ć•. 0.25% uridine =Š" MPU ıēĖ) 30°C24 ˙ı Œ°£Ċ=gtRYZIe@vW)Ø£"£ĊŌ 4 g = 40 mL -gx\gt R\ęô„0.38% Novozyme2340.12% Cellulase “ONOZUKA” R-100.8 M NaCl 10 mM NaH2PO4 (pH 5.8) Ė) 30°CŌ 2 ˙AyHrh\"-„=gtR YZIe@vW);°;„= êŁŕ(ĚĠ=Ö0.8 M NaCl ŏ„) 2 Ģ÷æ 0.8 M NaCl-50 mM CaCl2 ŏ„) 1 Ģ÷æ"Ħ7:"ĚĠ, 0.8 M NaCl-50 mM CaCl2 ŏ„=Ō 100μl Š(«Đ:=gx\gtR\„*"gx\g tR\„ 50 μl , DNA ĒńŌ 5μg * 12.5 μl - PEG ŏ„25% PEG6000 in 50 mM CaCl2, 10 mM Tris-HClpH 7.5 =Š(ĸã) 20 Ł™ŅÊ7,ã- PEG ŏ„= 500μl Š(ĸã) 5 Ł™ŅÊ"-„, 1 mL - 0.8 M NaCl-50 mM CaCl2 ŏ„ =Š(º¸"°ŋ£gtRYZIPqw,Łė10 mL -¼óıē21.9 % Sorbitol, 1% Glucose, 0.6% NaNO3, 0.15% KH2PO4, 0.05% KCl, 0.05% MgSO47H2O, a trace of FeSO4H2O, 2% Bacto agarpH 6.5 =Š(¯ˆ30°C )Ō ×™ıŒ (¦Îĝ˜•=ÓĦ".

(56)  A. oryzae øéĊ DNA -ęôPCR 60 DNA PIDyR A. oryzae -øéĊ DNA .GP ıē) 30°C3 ĩ™ıŒ" A. oryzae -£Ċ= Ø£(îŁ=ß¡"°ģ©–ā(ł¾eCbv-Ixxjvoň)ę ô"Sambrook and Russell, 2001; Raeder and Bronda, 1985  PCR Ő¶ü.TaKaRa Ex Taq DNA luptTTakara Bio, Otsu, Shiga 60 PfuUltra II Fusion HS DNA polymeraseStratagene, La Jolla, CA, USA =ÇŐ. :. !:-gx\Mv,Ü(ij†=µ%"PCR ăĔ. GeneAmp9700 OmvOAI tApplied Biosystems, Foster City, CA, USA =ÇŐ"Ď â)ÇŐ"Eu N`IwEY]gtAm= Table 1-2 ,Ì". 12.

(57) Ò+Ix_yJR[Zg).model 4000LS DNA PKyOLI-COR, Lincoln, NE, USA 60 GenomeLab GeXPBeckman Coulter, Brea, CA, USA =Ő "PIDyPyJ,68óñŀ=“ī".

(58)  pyrG ~ğÈÃßŐhIW60 ku70 ~ğÈÃßŐhIW-³ĕ pyrG ~ğÈÃßŐhIWpDispyrG .z‡-6,³ĕ"pyrG ~ğÈ GenBank/EMBL/DDBJ accession no. AB017705, NITE DOGAN ID: AO090011000868 - 5’-Śöř 1.6-kb = A. oryzae øéĊ DNA *gtAmi? pyrG11/pyrG12 =Ő (Ąľï®¶ü SacI * XbaI )áˆ"pyrG ~ğÈ- 3’-Śöř 1.4-kb = A. oryzae øéĊ DNA *gtAmi? pyrG13/pyrG14 =Ő(Ąľ ï®¶ü XbaI * HindIII )áˆ"

(59) &-Ēń= pUC18 - SacI-HindIII ļ{,ĀĪpyrG ~ğ ÈÃßŐhIWpDispyrG =Âô" ku70 ~ğÈÃßŐhIWpDelku70-2 .z‡-6,³ĕ"ku70 ~ğÈ GenBank/EMBL/DDBJ Accession No. AB214649 - 5’-60 3’-Śöř. :!:. 1.0-kb = A. oryzae øéĊ DNA *gtAmi? ku70-1/ku70-6 60 ku70-72/ku70-82 =Ő(Ąľ" ku70 ~ğÈM]ř-ļ 1.0-kb Ēń= A. oryzae øéĊ DNA *gtAmi? ku70-9/ku70-10 =Ő(Ąľ":7- 3 &- PCR Åŀ=º ¸"5-=[ygw\*(gtAmi? ku70-1/ku70-10 =Ő(erQ sy PCR =µ%"erQsy PCR Åŀ= pUC18 - SmaI ļ{,OfIxyˆ ( pDelku70-1 =Âô"A. oryzae øéĊ DNA *gtAmi? pyrGN2/pyrGC2 =Ő(Ąľ" pyrG ~ğÈĒń 1.8-kb = StuI )áˆ( pDelku70-1 - Aor51HI ļ{,ĀĪku70 ~ğÈÃßŐhIWpDelku70-2 =Âô" A. oryzae -Lboäņ.ħŖµòňíôĺʼnŸÛ›Ĵœ³NITE http://www.bio.nite.go.jp/dogan/top 7ÓĦ". 13.

(60) Table 1-2. Oligonucleotide primers used in Chapter 1 Primer. Sequence. pyrG11. 5'-GCGAGCTCTACATTGGCAAAGGAAT-3'. pyrG12. 5'-GGTCTAGAATATTTAATCAGCTACC-3'. pyrG13. 5'-TGTCTAGACACTAGCTATACCGCCC-3'. pyrG14. 5'-CTAAGCTTATCAGCTGCATATCTCT-3'. pyrGN2. 5'-CAAGGCCTGCTGGAATTGACATTATTATGG-3'. pyrGC2. 5'-AAAGGCCTGATCAATACCGTACGGGAGATT-3'. ku70-1. 5'-TGGAATTCGGACCATTTTCGGATAGG-3'. ku70-6. 5'-AGAAGCTTTCAGGTGTGTTTGAAAG-3'. ku70-72. 5'-TCAAACACACCTGAAAGCTTCTGCCAACTTCCTGCAC-3'. ku70-82. 5'-CTGCGTCCCATATAATAGCGCTTTCGTCCGTTTGGATATA-3'. ku70-9. 5'-AAAGCGCTATTATATGGGACGCAGG-3'. ku70-10. 5'-CCGTCGACCATAGCCCCCAGAACAG-3'. ku70-11. 5'-AGCATGCATTTCTGGGATTAGACAGG-3'. amyRN1 5'-TTGAATTCGATCCCTGACTAGAGTC-3' amyRC1 5'-TTGGATCCAATCCTTCGGTTTACTA-3'. 14.

(61)  Ï­©Œ60´Ä.  pyrG ~ğÈÃߕ-ÂÚ ĉ- A. oryzae -¦Îĝ˜Ňň.ś/ niaD ~ğÈKitamoto et al., 1995 sC ~ğÈYamada et al., 1997 pyrG ~ğÈKitamoto and Yoshino, 1999 argB ~ğÈ Gomi et al., 1987 60 adeA ~ğÈJin et al., 2004 -6+ƒŒő ~ğÈm F-ÇŐ,›'(9Table 1-1 . -Ė)ExYQy-5′-uyÆFvkH. PtT=M]9 pyrG ~ğÈ-ÇŐ.lQ[@fSwIPsy*aG[@f SwIPsy-ŗŇ‹ĭ)9"4č+œĞ9BuQyBtPvĶő  ð•.BuQyBtPvĶĜŠıēĖ)ùIJ:ŇBuQyBtPvő  ð•. 5-fluoroorotic acid5-FOA ĜŠıēĖ)ùIJ:95-FOA .BtPvú ¤ĊExYyÆ-?^xJŀÎ)8Éç£-ó€=Ęþ’9"%( BuQyBtPvĶő ð•. 5-FOA ĆÀ‡).ó€)+. O F. HN O. O. N H. HN. COOH. O. 5-FOA. O HN O. N H. O. PyrF COOH N H Orotic acid. O. O. PyrG. HN N. COOH. RP. CTP. HN O. N RP. UTP. Fig. 1-2. Uracil biosynthesis pathway 15. Uracil. UDP. UMP.

(62) A. B M. pDispyrG. pyrG11. 2. 3. (kb) 23.1 9.4 6.6 4.4. (5.7 kb). pyrG14. KBN630. 1. pyrG. 2.3 2.0. 4.8 kb Transformation 5-FOA selection KBN630-17 pyrG). pyrG11. 0.6. pyrG14. 3.0 kb. Fig. 1-3. Construction scheme and confirmation of the pyrG deletion mutant. A. Scheme of the pyrG deletion is shown. PCR-amplified DNA fragments from a pyrG deletion vector, pDisPyrG, were transformed to A. oryzae KBN630, and 5-FOA resistant transformants were selected. A pyrG deletion mutant, A. oryzae KBN630-17, was obtained. Black and gray boxes indicate the 5’- and 3’-flanking regions of the pyrG gene, respectively, and the open arrow indicates the pyrG gene region. The direction of the arrow indicates the orientation of the pyrG gene. Small arrows indicate the position of oligonucleotide primers used. B. Agarose gel electrophoresis of amplified DNA fragments in the pyrG gene region of the 5-FOA resistant transformants using primer pair pyrG11/pyrG14. Parental strain, A. oryzae KBN630 (Lane 1), the pyrG deletion mutant. A. oryzae KBN630-17 (Lane 2), and the pyrG undeleted mutant, A. oryzae KBN630-19 (Lane 3) are shown.. 16.

(63) ŊûՁq A. oryzae KBN630 •- pyrG ~ğÈÃßŃ|•=ÓĦ9"4, pDispyrG =[ygw\*(gtAmi? pyrG11/pyrG14 =Ő( PCR Ąľ= µĦ7:" DNA Ēń=Ő( A. oryzae KBN630 •=¦Îĝ˜"Fig. 1-3 A  Uvc\vBuQy60BtPv=š3 CD ½àıēã,ó€("¦Î ĝ˜•-ã,5-FOA Čð¦Îĝ˜•=ùIJ9"4,7, 5-FOABuQy 60BtPv=š3 CD ½à—ěıē=Ùÿ"Ħ7:" 9 •- 5-FOA Čð•- $2 •BuQyBtPvő ð=Ì"pyrG ~ğÈ-Ãß.gtAmi? pyrG11/pyrG14 =Ő" PCR ,6%(“ī"ì• A. oryzae KBN630 -øéĊ DNA 7. 4.8-kb ĒńĄľ: Fig. 1-3 B, Lane 1 pyrG ~ğÈÃߕ-øéĊ DNA 7. 3.0-kb ĒńĄľ:"2 •-BuQyBtPvő ð•-$ŇA. oryzae KBN630-17 •. pyrG ~ğÈÃßŃ|•)8Fig. 1-3 B, Lane 2 ĈŇA. oryzae KBN630-19 •. pyrG ~ğÈÃßŃ|•).+%"Fig. 1-3 B, Lane 3   A. oryzae KBN630-17 •= pyrG ~ğÈKitamoto and Yoshino, 1999 =Ő(¦Îĝ ˜9*)BuQyBtPvĶő ðĽ":7-©Œ7ŊûŐ ¹£ A. oryzae KBN630 •,(pyrG ~ğÈ=ùďmF*9¦Îĝ˜§ “Ŗ"*Ì:".

(64)  pyrG, ku70 ĨÙÃßŃ|•-ÂÚ ku70 ~ğÈÃßFSZ\=¿"gtRn] pDelku70-2 = A. oryzae KBN630 pyrG, ku70 ĨÙÃßŃ|•-³ĕ,ÇŐ"Fig. 1-4 A gtAmi? ku70-1/ku70-10 [ygw\ pDelku70-2 =ÇŐ" PCR ĄľĒń=Ő( A. oryzae KBN630-17 •= ¦Îĝ˜"¦Îĝ˜•7gtAmi? ku70-1/ku70-11 =ÇŐ( PCR =µ Ąľ" DNA Ēń=¬Ú9Ňň)¦Îĝ˜•=ę2"ę2" 100 •-¦Î ĝ˜•-$ 8 •,&(6.3-kb ĒńFig. 1-4 B, Lane 2 ¬Ú:, Ňì•) . 3.6-kb ĒńFig. 1-4 B, Lane 1 ¬Ú:"-*.PCR )Ąľ" ku70. 17.

(65) A. B pDelku70-2 (7.5 kb). (kb). pyrG. Ku70-1. 1. 2. 3. 23.1 9.4 6.6 4.4. Ku70-11. KBN630-17. M. ku70 3.6 kb ku70 gene disruption. KBN630-17K (ku70) Ku70-1. Ku70-11. pyrG. ku70. 2.3 2.0. 6.3 kb. 0.6. 5-FOA selection KBN630-17K3. Ku70-11. Ku70-1. 2.1 kb. Fig. 1-4. Construction scheme and confirmation of the ku70 deletion mutant. A. Scheme of the ku70 deletion is shown. PCR-amplified DNA fragments from a ku70 deletion vector, pDelku70-2, were transformed to A. oryzae KBN630-17, and ku70 disruption mutants were selected. A ku70 disruption mutant, A. oryzae KBN630-17K3, was obtained. Then, a ku70 deletion mutant was selected on 5-FOA treatment of A. oryzae KBN630-17K3. Black and gray boxes indicate the 5’- and 3’-flanking regions of the ku70 gene, respectively. The open and black arrows indicate the pyrG and ku70 genes, respectively. The direction of the arrow indicates the orientation of the ku70, pyrG genes. Small arrows indicate the position of oligonucleotide primers used. B. Agarose gel electrophoresis of amplified DNA fragments in the ku70 gene region of the ku70 disruption and deletion strains using primer pair ku70-1/ku70-11. Parental strain, A. oryzae KBN630-17 (Lane 1), the ku70 disruption mutant, A. oryzae KBN630-17K (Lane 2), and the ku70 deletion mutant, A. oryzae KBN630-17K3 (Lane 3) are shown. 18.

(66) ~ğÈÃßFSZ\ ku70 ~ğÈ»,ĥĪ:"*=ÌĦ7:" ku70 į‘Ń |•-$-•)9 A. oryzae KBN630-17K •=z·-Ï­,ÇŐ"ku70 ~ ğÈÃßFSZ\ ku70 ~ğÈ»1ĥĪ:9*,6%(ku70 ~ğÈ- 1.0-kb - 3′-Śöř pyrG ~ğÈ* ku70 ~ğÈ=¢>#ŗą,XAwI\ud\-¦ )ÙĿ9:7-ĤİŜ™)ĂĤý˜ž9*,685-FOA )ÞŔ 9* pyrG ~ğÈ60 ku70 ~ğÈÃß:9pyrG ~ğÈ60 ku70 ~ğÈ= Ãß9"4, A. oryzae KBN630-17K •-ŁóÈ= 5-FOABuQy60BtPv =ĜŠ" CD —ěıē,ġʼn5-FOA ČðMx_=ùIJ":7-Mx_ .Ō 1  10-2 -ĻĢ)Ħ7:"pyrG ~ğÈ60 ku70 ~ğÈ-¬Ú.gtAm i? ku70-1/ku70-11 =ÇŐ" PCR ,68µ%"Ąľ" DNA Ēń=¬Ú9 Ňň)¦Îĝ˜•=ę2"A. oryzae KBN630-17K •-øéĊ DNA 7. 6.3-kb Ē ńFig. 1-4 B, Lane 2 Ąľ:5-FOA Čð• A. oryzae KBN630-17K3 •-øé Ċ DNA 7Fig. 1-4 B, Lane 3 Ąľ:":7-©Œ7KBN630-17 • - ku70 ~ğÈÃß,ñ±"*Ì:".  pyrG, ku70 ĨÙÃßŃ|•,9~ğÈWLZ[@yJĻĢ ku70 ~ğÈÃß-~ğÈWLZ[@yJĻĢ,Ŏ9²Œ=ę29"4,A. oryzae KBN630-17K3 •= amyR ~ğÈį‘ŐhIWpDisAmR100Kitamoto et al., 2006 -ï®¶ü EcoRI 60 SalI áˆŀ=Ő(¦Îĝ˜" ¼ó" pyrG+ ¦ Îĝ˜•= CD —ěıēã)ùIJ(݈RWY—ěıē,}"AmyR . ?ntT~ğÈ¥-ōĥĝЂÈ)9"4Petersen et al., 1999 amyR+-¦Î ĝ˜•.RWY—ěıēã)ó€"°, KI-I2 øé=µ*Iu?Vy=¦ ñ9amyR ~ğÈį‘•. Iu?Vy=¦ñ+50 •-¦Îĝ˜•Ė 46 •.Iu?Vy=¦ñ+%"+<$92%-¦Îĝ˜• amyR ~ğÈ į‘•)8:7-•,(ĂĤý˜ž%"*´7:"amyR ~ğ. 19.

(67) A. B pDisAmR100 (6.8 kb). M. 23.1 9.4 6.6 4.4. amyRC1. amyRN1. amyR 2.9 kb amyR gene disruption. 2.3 2.0 0.6. amyRC1. amyRN1. amyR. 2. (kb). pyrG. KBN630-17K3. 1. pyrG 3.6 kb. Fig. 1-5. Construction scheme and confirmation of the amyR disrupted strain. A. Scheme of the amyR disruption is shown. The amyR disruption vector pDisAmR100 digested with EcoRI and SalI was transformed to A. oryzae KBN630-17K3, and the transformants with no amylase activity were selected. Black and white arrows indicate the amyR and pyrG genes, respectively, and the direction of the arrows indicates the orientation of the respective genes. Small arrows indicate the position of oligonucleotide primers used. B. Agarose gel electrophoresis of amplified DNA fragments in the amyR gene region of the transformants with no amylase activity using primer pair amyRN1/amyRC1. Parental strain, A. oryzae KBN630-17K3 (Lane 1), the amylase-negative transformant (Lane 2) are shown.. Èį‘hIWpDisAmR100 ,6%(ì•- amyR ~ğÈĔ˜:"ĵ=g tAmi? amyRN1/amyRC1 =Ő" PCR õ,6%(“4"Fig. 1-5 A ì • A. oryzae KBN630-17K3 •-øéĊ DNA ). 2.9-kb ĒńĄľ"-,ċFig. 1-5 B, Lane 1 ?ntTĶóÅð¦Îĝ˜•-øéĊ DNA ). 3.6-kb ĒńĄľ "Fig. 1-5 B, Lane 2  A. oryzae KBN630-17K3 •,9~ğÈWLZ[@y. 20.

(68) RƖŻ0A. oryzae KBN616 §/ ku70 ˆŹûƉ §82.3%Kitamoto and Yasuda, 2008; A. oryzae RIB40 / ku70 ˆŹûƉ §63.4%Takahashi et al., 2006b/ "A=?ã'$A>/ŗ>ƒŌſĶƭşđƙ/ƖŻ0 A. oryzae §®*: ê/@+ĄéA$/ŗ0˜¹.ƥæA$ȸŗTakahashi et al., 2006b+0‡-')$ A6*/ƥæ+ſƺ.Takahashi et al., 2006a; Takahashi et al., 2006bku70 ˆ Źû/Ɖ 0ĺŠőŻ;ƨû/Ũĺ=1ƌ›+'$Ɣο.0¼Dƹ- '$ku70 ˆŹûƉ §+ 5-FOA Dœ$ pyrG ˆŹû/ôĞ/ďƧDŊ7äC!@ +.=?vND~WIQ)ſ‹§ũ*ØǃŴ.ƛĴ/ˆŹûDôĞ. @. +–ƈ*@Takahashi et al., 2008<.pyrG, ku70 ƂĕôĞƢ‡§*@ A. oryzae KBN630-17K3 §0ƮŇå½ĈƼ§ A. oryzae KBN630 /Ɓų/ĪŏƁĶž ƲDƳŴ+)ÜƎ†/ˆŹûôОĽDà.$?»lj-a+-@/ ØǃŴ-ˆŹûŤ¬XZbxDƼ@+.=?ƺ-ˆŹû/Ɖ Dü$Ʈ Ň/ļŏ.ŵ$ƮŇå½ĈƼ§/óė³ŗ*@.   ƽƴ ƮŇƼå½ Aspergillus oryzae KBN630 §.) pyrG ˆŹûM_Y‚- 5’ -~ ‚øcNtOX}]ˆŹûôЧDƝǂpyrG ˆŹûDńŜvN+ @ÀćŸ¬ÂD¡ƌ$ŌſŊ¬.=@¢ǀˆŹû/łĬŕĤ3/Ŋç7ƖŻD ÚĤ!@$9.A. oryzae KBN630 §.ƶǀ. @ pyrG ˆŹûôЧ/TjxĤ. > DNA ƂƫìĿŠđƙ´Þ/ (ƒŌſƭşÅäđƙÂ.¯C@ Ku70 ^‚lQ ćDUe. @ ku70 ˆŹûDй$Ďƀ$ pyrG, ku70 ˆŹû ĕôЧ.. ) amyR ˆŹû/Ɖ Dā7$+B90% „Ĥ/ƖŻ* amyR ˆŹûDƉ . @. +*$/ŗ=?ƮŇƼå½ A. oryzae KBN630 §.)ãƖ݈Źû ŌſŊ¬ÂD£DŽ. @+*$. 21.

(69) ś Ģ ƮŇƼå½.@øĶsZnF^] A ˆŹûaphA/Ɖ + AphA / ĝĶć/žƲ   ĝÏ ƮŇ/ƮDÚĤ!@$9. 5'IjX‚øƂfd~Jx5'IMP; 5'R GgøƂfd~Jx5'GMP/=- 5'-~thQ€M_eƂfd~Jxŷ• A$ŬƮƮŇ%Ƅ?ƮҕÛƕļŏA)@ËƮŇũ.05'-~th Q€M_eƂfd~JxDŝ~‚ø”)ýƮ/-~thQ€MXeDĺķ. @. âʼnsZnF^]°6A)@"*ƮŇåũ/sZnF^]¦ĶŪ ű“$ƮŇƼå½ A. oryzae ½§Dóė. @+.=')sZnF^]Ʀ. /$9/㒕ƆěǁDŸƑ$Įµ-ġLiP¿/%Ƅ?ŬƮƮŇļŏ¶ Ę/¡ƌ–ƈ*@+ß>A@ A. oryzae ƝƐ. @sZnF^]+nH^].¯)A6*.(/. ȸƥæA)@"A>/âʼn/ 5'~thQ€M_e.Ŗ. @Ɲž¦Ķ.. ()05+E,š>A)-Fujishima et al., 1964, Wang et al., 1980, Oike et al., 1984, Shimizu., 1993, Fujita et al., 2003a, 2003bnH^]0sZnF^]WoQ }Z/mZ_Y‚øĶsZnF^]nFw~.Œ. @nH^]0īƜĐû. .@čƽ-~‚øūŧÀŘ*@nH_‚øDØǃŴ.•ijƝž~‚øDƷ ǂ. @ÿĨ½ƶǀ/nH^]0øĶsZnF^]Acid phosphataseAph. ¦Ķ/Őų.Ƽ>A@l}gd~‚øPNPPD±ć+$ĥä.:¦ĶDĄ +š>A)@Mitchell et al. 1997, Wyss et al. 1999bA. oryzae RIB40 §ƶǀ / n H ^  ] ˆ Ź û / cDNA Ɗ Nj 0  c  ^ q  Z Ĥ . × ¡  A )  @ GenBank/EMBL/DDBJ accession no. AB042805"/ˆŹû÷Ɯ0ĻļAĶć/ ‹ƘƲ>.A)@Uchida et al., 2006™0"/ˆŹû÷ƜnH_‚ ø=?: PNPP D±ć.$ĥä.=?ã¦ĶDĄ$+>"/ˆŹûDø ĶsZnF^] A ˆŹûaphA ˆŹû+Ʊư$. 22.

(70) ś Ģ*0ś Ģ*¡ƌ$ƮŇƼå½ A. oryzae KBN630 §/ãƖ݈ŹûŌſ Ŋ¬ÂD¦Ƽ) aphA ˆŹûDƉ ŽƮŇƼ/å.@øĶsZnF^ ]¦Ķ/Ƣ”D­ö$ă.å½.@»lj-pz^*@ TEF1 ˆŹ ûpz^Kitamoto et al., 1998D¦Ƽ) aphA ˆŹûDãƌÎ!AphA DƝƐĺ÷!@+º.AphA DĻļ)âʼn¥ŴĝĶćDžĽ$.   ĈÊòdž=1ĈÊƦƧ    úƼ½§ ƮŇƼå½§ A. oryzae KBN630 §D DNA Ŭļ.úƼ$ś 1 Ģ*óė$ A. oryzae KBN630 §ƶǀ/ pyrG, ku70 ˆŹûƂĕôĞƢ‡§*@ A. oryzae KBN630-17K3 §=1ģƵƼå½ KBN616 §ƶǀ/ alp, pyrG ˆŹûƂĕƉ Ƣ ‡§*@ A. oryzae PDE1 DÀćŸ¬ƼĖč+)úƼ$A. oryzae PDE1 §0 Ŋ¬^‚lQćDØǃ=ĺ÷!@$9.GN~pbG]ˆŹûalp ˆ Źû Murakami et al., 1991DƉ $§*@ƫ§/óļƦƧ.()0, ơ/´.ƌƔ. @Ƹų*@. E. coli DH5 α DĐ/ DNA Šƣ/Qg‚R.úƼ$.    ƋŢ=1ƋƾħÆ A. oryzae /ŕƋƾ.0Ơ*E2EƋŢRS ƋŢ 3% rice starch1% polypeptone 1% NaNO30.2% KCl0.1% KH2PO40.05% MgSO4.7H2ODúƼ) 30°Cƴ 160 rpm /ŸŸąĭ+ƋƾDà'$ ŽåƋƾ0ĩĊŚŽr€`dDƋƾ±+) 30°C43 Ă®/ƋƾDà'$ĩ ĊŚŽr€`d0ŚŽDij. 2 Ă®įŰÒ35 ƝĩĊ)*$ĩĊŚŽDw‚_ ´*ŮÁƴ 10 mmŭ 15 ~ 20 mm .ķÀ)úƼ$ E.coli /Ƌƾ.0 2xYT ƋŢ 1.6% Bacto tryptone1.0% Bacto yeast extract0.5% NaCl. 23.

(71) DƼ Ɠƽ.‘)ƇŻ 50μg/mL / ampicillin sodium Dŷ•ÑŕƋƾĂ.0 1.5% Agar Dŷ•$Ƌƾ0 37°C .)à'$.  

(72)  A. oryzae /ÀćŸ¬ A. oryzaepyrGD MPU ƋŢ2.0% malt extract0.1% Bacto peptone2.0% glucose 0.25% uridinepH6.5ũ* 30 24 Ă®ƋƾÒ  

(73) .Ą$ƦƧ+ſƺ. Novozyme234 =1 Cellulase “ONOZUKA” R-10 DƼ)pdp}Zd”$ƀ >A$pdp}Zd. PEG œñ“* DNA Šƣ/Ď?ç7DàC!)ÀćŸ¬Dà íĺ©ŶƋŢũ* 30°Cƴ Ē®Ƌƾ)ÀćŸ¬§DĎƀ$.    A. oryzae łĬŕ DNA /ŬļPCR =1 DNA XQL‚Z A. oryzae /łĬŕ DNA 0GP ƋŢ* 30°C3 ƃ®Ƌƾ$ A. oryzae /½ŕD ē½)ijƝDй$ÒżÅ¨ŋ)ƞïnKj-QsxƧ*Ŭ ļ$Sambrook and Russell, 2001; Raeder and Bronda, 1985 PCR Ƽâʼn0TaKaRa Ex Taq DNA u~y}]Takara Bio, Otsu, Shiga=1 PfuUltra II Fusion HS DNA polymeraseStratagene, La Jolla, CA, USADúƼ"A #A/pdU.Ě)ƍ‘Dà'$PCR ōŤ0 GeneAmp9700 WvWIQ }Applied Biosystems, Foster City, CA, USADúƼ$ś Ģ*úƼ$M~ VhQ€M_ep}IvD Table 2-1 .Ą$ č-Qg‚RZb`p*0model 4000LS DNA XS‚WLI-COR, Lincoln, NE, USA=1 GenomeLab GeXPBeckman Coulter, Brea, CA, USADƼ$X QL‚X‚R.=?ĺķƜD£ƅ$.   aphA ˆŹûƉ ƼqQ^/ÞŦ aphA ˆŹûƉ ƼqQ^pDisAphA D„“/=.ÞŦ$aphA ˆŹû/. 24.

(74) Table 2-1. Oligonucleotide primers used in this study Primer. Sequence. phyA1. 5'-TCGAGCTCGGTACCCCTGTTCATTTTGGTTGAGAA-3'. phyA2. 5'-CAGCGGCTTGATCAACTCGTACAAGGCGAC-3'. phyA3. 5'-TTGATCAAGCCGCTGCTGGAATTGACATTA-3'. phyA4. 5'-GTGACGGGAGATTGTACGAACAGATGGCCC-3'. phyA5. 5'-ACAATCTCCCGTCACGGTGCACGGTATCCA-3'. phyA6. 5'-CTCTAGAGGATCCCCAGTTTCCACCCGATGTAACG-3'. fupyrGN 5'-CGGTACCCGGGGATCCAAGCCGCTGCTGGAATTGACA-3' pyrGC2. 5'-AAAGGCCTGATCAATACCGTACGGGAGATT-3'. pyrGtef. 5'-ATTGATCAGGCCTTTCACTGTGGACCAGACAGGC-3'. tefPrev. 5'-CATTTTGAAGGTGGTGCGAACTTTG-3'. tefaphA. 5'-ACCACCTTCAAAATGGCGGTCCTTAGCGTGCTCCTTC-3'. aphASal. 5'-ATGCCTGCAGGTCGACTGAGGAGAGGAAGGATGGG-3'. 5’-NJŀLj‰ 1.0-kb + 3’-NJŀLj‰ 1.1-kb D"A#A A. oryzae łĬŕ DNA +p}I vrG phyA1/phyA2 =1 phyA5/phyA6 DƼ) PCR Ŏƚ$pyrG ˆŹûŠ ƣ 1.8-kb D A. oryzae łĬŕ DNA +p}IvrG phyA3/phyA4 DƼ) PCR Ŏ ƚ$ƀ>A$ 3 (/ PCR ŎƚŠƣ+ SmaI *Ġ”$qQ^pUC18 /äà 4 ŠƣDèäIn-Fusion Advantage PCR Cloning KitTakara BioDƼ) In-Fusion ƍ‘Dà'$/=.)ƀ>A$aphA ˆŹû/ 5’-NJŀLj‰+ 3’-NJŀLj‰/ ®. pyrG ˆŹû Ť. @p}ZweD pDisAphA +$.   aphA ˆŹûƌÎƼqQ^/ÞŦ aphA ˆŹûD A. oryzae TEF1 ˆŹû/pz^ĵӓ*ƌÎ!@$9. 25.

(75) ƌÎƼp}Zwe pTFAphA D„“/=.ÞŦ$pyrG ˆŹûŠƣ 1.8-kb D A. oryzae łĬŕ DNA +p}IvrG fupyrGN/pyrGC2 DƼ) PCR Ŏƚ$A. oryzae TEF1 ˆŹûpz^/ 0.8-kb ŠƣD A. oryzae łĬŕ DNA +p}Iv rG pyrGtef/tefPrev DƼ)Ŏƚ$aphA ˆŹû 2.0-kb ŠƣD A. oryzae łĬŕ DNA +p}IvrG tefaphA/aphASal DƼ)Ŏƚ$ƀ>A$ 3 (/ PCR Ŏ ƚŠƣ+ BamHI/SalI *Ġ”$qQ^pUC18 /äà 4 ŠƣDèäIn-Fusion Advantage PCR Cloning Kit DƼ) In-Fusion ƍ‘Dà'$/=.)ƀ>A$ TEF1 ˆŹû/pz^ aphA ˆŹû/UeLj‰/NJ.ĸ£. Ť. @p}Z. weD pDisAphA +$.   A. oryzae ãĺ÷§>/ AphA ^‚lQć/ĻļGwjøƊNjÄų =1ŝR~UX” A. oryzae ÀćŸ¬§ APA4 DƠ*E2EƋŢRS ƋŢ* 5 ƃ®ĭ+Ƌƾ $½ŕDB˜)й$ÒƋƾĤĹ 150 ml .°6A@^‚lQćD 80% ƪnj /Džƒ*ůź10 mM Tris-HCl bufferpH 7.0.ƻžſk`nF.Ŗ)ž Ľ$ňĻļâʼnDſk`nF*Ɵá”$ HR16/20 Fast Flow Q-Sepharose ŒIM‚Ô¬N}xGE Healthcare, Buckinghamshire, UK./!0.0 M > 0.3 M NaCl /ŮŃÙƊ.=?ƻė$AphA D°8ƝšDſk`nF.Ŗ)žĽ íŻ HR16/20 Fast Flow Q-Sepharose ŒIM‚Ô¬N}x./!$")·Ũ$^ ‚lQćD 0.0 M > 0.3 M NaCl /ŮŃÙƊ.=?ƻė$ N ƭşGwjøƊNjDžĽ. @$9.ĻļâʼnD ProSorbApplied Biosystems. ōŤDƼ) PVDF Ƭ.ŸĉApplied Biosystems Procise 491 XQL‚WDƼ )ŁƲĜApplied Biosystems.Ĕ')ƊNjDÄų$Ļļâʼn/ŝR~UX ”0 endoglycosidase H Glyko, Novato, CA, USA DƼ)yNŁƲĜ.Ĕ') à'$endoglycosidase H Dŷ•. @Ņ.^‚lQć/ƢĶDà'$. 26.

(76)   âʼn¦Ķ/Őų øĶsZnF^]¦Ķ0Śţ>Oike et al., 1984/ƦƧDČ«ƢÝ)à'$ ‹ųLJ/âʼnD 100 mM ıøk`nFpH 4.0.ƻž$ 1 mM p-gdnK g~‚øPNPPƻũ* 40°C10 ƝI‚O{qd$âʼnƍ‘D 10% d ~QıøƻD•)Ųþ$ 2 M Şøfd~JxƻD•$ÒƷǂ $ p-gdnKjPNPLJD 405 nm /·ÖŻ.=?Őų$âʼn |g` d0ƫħÆ* 1 Ɲ®. 1 mol / PNP DƷǂ. @âʼnLJ+$ŽåƋƾ/ĥä0. øĶsZnF^]¦ĶŐų/ƍ‘ħÆ0 40°C10 Ɲ.ř)37°C20 Ɲ+ $âʼn/Āŵ pH 0ƺ- pH3.0 to 7.0/ 100 mM ıøfd~JxpH 4.0 ƻũ*âʼnD 40°C10 ƝI‚O{qd)Őų$ âʼn/Āŵ’Ż0 100 mM ıøfd~Jxƻũ*âʼnDƺ-’Ż25°C to 65°C* 10 ƝI‚O{qd )Őų$’ŻƒųĶ+ pH ƒųĶ0ƺ-’Ż25°C to 65°C* 30 ƝI‚O {qd$Ò+ƺ- pH3.0 to 7.0* 30°C1 Ă®I‚O{qd$Ò/ âʼn¦ĶD"A#AŐų$±ćƁ‡Ķ0„“/=.Ŭ4$100 mM ıøk` nFpH 4.0.ƻž$ 2 mM /±ćƻũ*âʼnD 40°C30 ƝI‚O{qd $Ʒǂ$Ư´~‚øLJD Phosphor C Test KitWako Pure Chemical, Osaka, Japan DƼ)Őų$ GnFGw}]¦Ķ0×ųƧNishiya 1993.Ĕ')Őų$ũĶpb G]¦Ķ0×ųƧNishiya 1993DČ«ƢÝ)Őų$k`nF0 McIlvaine bufferpH 3.0.ř) McIlvaine bufferpH 6.0DúƼ$. 

(77)  ĈÊŗ=1ßö 

(78)   aphA ˆŹû/ in silico Qg‚R+ˆŹûƉ  A. oryzae 0ƛĴ/øĶsZnF^]Aph=1nH^]Dĺ÷. @". /&(0ĻļAN ƭşGwjøƊNjÄųA)@Fujita et al., 2003a,. 27.

(79) A. B pyrG. 1. 2. 3. 4. 5. 6. 7. 8. (kb) phyA1. phyA6. 23.0 9.4 6.6 4.4. aphA KBN630-17K3 2.6 kb. 2.3 2.0. aphA gene disruption phyA1. phyA6. pyrG. aphA. 0.56. aphA 3.9 kb. Fig. 2-1. Construction scheme and confirmation of the aphA disrupted strain. A. Scheme of the aphA disruption is shown. PCR-amplified DNA fragments from a aphA disruption vector, pDisAphA, were transformed into A. oryzae KBN630-17K3. Gray and black boxes indicate the 5’-flanking region and a part of the coding region of the aphA gene, respectively, and the closed and open arrows indicate the aphA gene and pyrG gene regions, respectively. The direction of the arrow indicates the orientation of the aphA and pyrG genes. Small arrows indicate the position of oligonucleotide primers used. B. Agarose gel electrophoresis of amplified DNA fragments in the aphA gene region of the transformants using primer pair phyA1/phyA6.. 2003b"A>/GwjøƊNj.Ŗ‘ ZĤ.Éė%. @ˆŹûD A. oryzae Tjxc^q. +ėǀ-'$"/$9™0 A. oryzae Tjxc^q. Z> BLAST Çõ.=?IJųøĶsZnF^]ˆŹûDŬë$"/ŗ5 Ð/IJųøĶsZnF^]ˆŹû+ 8 Ð/IJųnH^]ˆŹûÉ('$IJ ųøĶsZnF^]ˆŹû/ƌÎ0ŚŽ.°6A@nH_‚øƶǀ/ƩƗ-~‚. 28.

(80) ø.=')ƿĵA@+ß>A$"/ǁƶ0"A>/ˆŹû Aspergillus niger MacRae et al., 1988; Penicillium chrysogenumHass et al., 1992ƶǀ/~‚øƿ ĵĶøĶsZnF^]+ŌſĶ@$9*@ù?/ÕƤˆŹû/ũ*Ķć =žƲA)@ A. niger phyA ˆŹûvan Hartingsveldt et al., 1993+î:Ō ſĶ/ãˆŹûNITE DOGAN ID: AO090023000692DńŜ$/ˆŹû0 A6*.ƥæA)@ A. oryzae RIB40 /nH^]ˆŹûGenBank/EMBL/ DDBJ accession no. AB042805Uchida et al., 2006+ſ‹*?aphA ˆŹû+Ʊ ư$")™0 AphA  5'-~thQ€M_e.Ŗ•ijƝžŝ~‚ø” ¦ĶDĄ. ,DŬ4$. aphA ˆŹûƉ §DĎƀ. @$9.p}Zwe pDisAphA Db‚p€d+. p}IvrG phyA1/phyA6 DƼ$ PCR Ŏƚ.=?ƀ>A$ DNA ŠƣDúƼ )\nQg‚R.=? A. oryzae KBN630-17K3 DÀćŸ¬$Fig. 2-1 A  ÀćŸ¬§.()p}IvrG phyA1/phyA6 DƼ$ PCR DàŎƚ$ DNA Šƣ/WI[.=?ÀćŸ¬§DŬ4$ Ŭ4$ 8 §/& 6 §.() 3.9-kb ŠƣÇėA$Fig. 2-1 B, lane 2 > 7‹Ʀù?/ 2 §.()0 3.9-kb Š ƣ.•) 2.6-kb ŠƣÇėA$Fig. 2-1 B, lanes 1 =1 8A>/ŗ= ?Ņċ/ 6 §.) aphA ˆŹûƉ A$+ĄéA$ƀ>A$ aphA ˆŹûƉ §/& 3 §Dă/āÊ.úƼ. @+.$. aphA ˆŹû/Ɖ Žåũ/øĶsZnF^]¦Ķ.ƹ@¼DŬ4@$9 .aphA ˆŹûƉ §/âʼnĺ÷ĶDݧ+Ə¤$3 §/ aphA ˆŹûƉ §0 º.ĩĊŚŽr€`d.ĸĦ.ĺŠ$$')aphA ˆŹû/Ɖ 0ĩĊ ŚŽDŽƾÍ+$ĥä/ĺŠ.¼Dƹ-+C'$Table 2-2 .Ą. =. .aphA ˆŹûƉ §/øĶsZnF^]/ĺ÷0ݧ.Ə4)ƴ 20% Ìğ $ƍŖ.Gw}]+ũĶpbG]/ĺ÷0ݧ.Ə4)ƴ 10% Ŏ•$ A>/ŗ>aphA ˆŹû/Ɖ Gw}]/=-Ŕ/âʼnĺ÷D>. 29.

(81) Table 2-2. Effect of aphA gene disruption on enzyme production Strain. -Amylase. Neutral protease. Acid phosphatase. (% of control). (% of control). (% of control). aphA-1. 778 ± 54.4 (122). 31,883 ± 1460.2 (110). 324 ± 30.5 ( 84). aphA-2. 721 ± 43.1 (113). 30,061 ± 1803.8 (104). 304 ± 32.7 ( 79). aphA-3. 695 ± 68.6 (109). 30,547 ± 601.0 (105). 309 ± 13.1 ( 80). A. oryzae KBN630. 636 ± 14.8 (100). 29,028 ± 338.0 (100). 387 ± 22.3 (100). The enzyme activity is shown as U/g koji. The activity of two independent experiments is presented as the average ± standard deviation.. Ŏ•!@–ƈĶĄéA$<.aphA ˆŹûƉ §*0Ŕ/øĶsZn F^]/ĺ÷DŎ•$–ƈĶ?aphA ˆŹûƉ /ؗ0Ĉð=?űÉ ľ:>A)@:A-aphA ˆŹû÷Ɯ/ņøĶsZnF^]¦Ķ. @²ƹǃDŬ4@$9.0Ŕ/øĶsZnF^]ˆŹû¾/Ɖ §DĎƀ)ž Ľ. @Ɠƽ@. 

(82)   AphA /ãƌÎ+Ļļ aphA ˆŹû÷Ɯ/âʼn¥ŴĶćDƲ>.. @$9.aphA ˆŹûD A. oryzae. TEF1 ˆŹûpz^/ĵӓ*ãƌÎ!$TEF1 ˆŹûpz^0 A. oryzae .)î:»pz^/‹(*@A. oryzae TEF1 ˆŹû/pz ^ĵӓ. aphA ˆŹûDŊçE%ƌÎqQ^pTFAphA D  *ę4 $=.ÞŦ$A. oryzae KBN630 §ƶǀ/ aphA ˆŹû0Fig. 2-268 bp /I ‚d‚ 1 ÐD°8 1,469 bp >ķ?"/±ƊNj0 A. oryzae RIB40 /nH^ ]ˆŹûGenBank/EMBL/DDBJ accession no. AB042805+ªņ.‹ť$ aphA 30.

(83) ATGGCGGTCCTTAGCGTGCTCCTTCCCATTACCTTCCTTCTCTCGAGgtaagctcacccatagatgctgccctatagtggatgccctaat M A V L S V L L P I T F L L S S. 90 16. ctaacagcggctgatcttcattcagTGTTACCGGCACTCCGGTGACCAGCCCGAGACAACAGTCGTGCAATACCGTTGACGAAGGCTACC V T G T P V T S P R Q Q S C N T V D E G Y Q. 180 38. AGTGCTTCTCCGGGGTCTCTCACTTGTGGGGCCAGTATTCGCCTTACTTCTCGGTCGACGACGAGTCTTCCTTGTCCGAAGACGTTCCGG C F S G V S H L W G Q Y S P Y F S V D D E S S L S E D V P D. 270 68. ACCACTGCCAGGTTACCTTTGCCCAAGTGCTCTCCCGTCACGGTGCACGGTATCCAACGAAGAGCAAGTCTGAGAAGTACGCCAAGCTCA H C Q V T F A Q V L S R H G A R Y P T K S K S E K Y A K L I. 360 98. TCAAGGCCGTCCAGCATAATGCTACCTCGTTCTCCGGGAAGTATGCGTTCCTGAAATCTTACAACTACTCCCTCGGCGCCGATGACCTTA K A V Q H N A T S F S G K Y A F L K S Y N Y S L G A D D L T. 450 128. CGCCTTTTGGAGAGAACCAGTTGGTGGATTCGGGGATCAAGTTCTACCAGCGCTATGAGGAGCTCGCCAAGAACGTCGTTCCTTTCATTA P F G E N Q L V D S G I K F Y Q R Y E E L A K N V V P F I R. 540 158. GGGCATCGGGTTCGGATCGGGTAATCGCATCCGGCGAGAAATTCATCGAGGGCTTCCAGAAGGCAAAGCTTGGTGACTCTAAGTCTAAGC A S G S D R V I A S G E K F I E G F Q K A K L G D S K S K R. 630 188. GGGGCCAGCCTGCTCCTATTGTCAACGTAGTTATTACTGAGACCGAGGGTTTCAACAACACGTTGGACCACAGTCTCTGCACGGCCTTTG G Q P A P I V N V V I T E T E G F N N T L D H S L C T A F E. 720 218. AGAACAGCACAACAGGGGATGACGCAGAGGACAAGTTCACCGCTGTTTTTACGCCCTCGATTGTTGAGCGTCTGGAGAAGGACCTCCCAG N S T T G D D A E D K F T A V F T P S I V E R L E K D L P G. 810 248. GAACCACGCTCTCCAGCAAAGAGGTGGTTTATCTGATGGACATGTGCTCATTCGACACCATCGCCTTGACCCGTGACGGCAGTCGGCTAT T T L S S K E V V Y L M D M C S F D T I A L T R D G S R L S. 900 278. CCCCCTTCTGCGCTTTGTTCACCCAGGAAGAATGGGCACAATATGACTACCTGCAGTCAGTCTCTAAGTACTACGGCTACGGTGGAGGAA P F C A L F T Q E E W A Q Y D Y L Q S V S K Y Y G Y G G G N. 990 308. ACCCTCTCGGACCTGCGCAGGGCATCGGCTTCGCTAACGAGCTGATCGCTCGCCTGACCAAGTCTCCGGTTAAGGATCACACCACCACCA 1080 P L G P A Q G I G F A N E L I A R L T K S P V K D H T T T N 338 ATACCACGCTGGACTCAAATCCCGCCACCTTCCCGCTGAATGCTACGCTCTATGCGGACTTCTCGCACGATAACACGATGACCTCCGTTT 1170 T T L D S N P A T F P L N A T L Y A D F S H D N T M T S V F 368 TCTTCGCGCTTGGTCTGTATAATACGACCGAGCCCCTCTCTCAGACTTCGGTGCAGTCCACTGAGGAGACGAACGGATATTCATCCGCCC 1260 F A L G L Y N T T E P L S Q T S V Q S T E E T N G Y S S A R 398 GGACCGTTCCATTCGGGGCCAGAGCCTACGTCGAGATGATGCAGTGCACGGATGAGAAGGAGCCTCTCGTCCGCGTACTGGTCAACGACC 1350 T V P F G A R A Y V E M M Q C T D E K E P L V R V L V N D R 428 GGGTCATTCCGCTGCAAGGCTGTGATGCTGATGAGTATGGCCGGTGTAAACGGGACGATTTCGTCGAAGGACTGAGCTTCGTTACATCGG 1440 V I P L Q G C D A D E Y G R C K R D D F V E G L S F V T S G 458 GTGGAAACTGGGGAGAGTGCTTTGCTTAA 1470 G N W G E C F A * 466. Fig. 2-2. Nucleotide and deduced amino acid sequences of the aphA gene from A. oryzae KBN630. Numbers on the right refer to nucleotide sequence and amino acid sequence. Intron sequence is in lower-case letters. An asterisk (*) marks the translation stop codon. The N-terminal amino acid sequence analyzed chemically is thick-underlined. Potential N-glycosylation sites are fine-underlined.. 31.

(84) Table 2-3. Summary of purification of AphA from A. oryzae APA4 Specific Total. Total. Purification step. Recovery. Purification. (%). (fold). Activity activity (U) protein (mg) (U/mg). Culture filtrate. 1,414. 56.4. 25.1. 100.0. 1.0. 485. 18.4. 26.4. 34.3. 1.1. Q-Sepharose HP (1st). 361. 3.9. 92.5. 25.5. 3.7. Q-Sepharose HP (2nd). 303. 2.8. 108.4. 21.4. 4.3. Ammonium sulfate precipitation. ~ĻÖ½Ŏ¯hMWpTFAphA B A. oryzae PDE1 •0Łņ RS ōĨ,ōŹ Đŏ. åł. &§á噕B. &ōʃĬ1 Aph ”ĆBĚĴ">-0;=AphA ½ĉЕB. &30 •1§á噕1jTeDWV”Ć2 2.3 ~ 12.1 U/ml21 ~ 112 mg/l. ,=$?0Ġ. +Ġ÷•"/A' pyrG ~ĻÖBŁņ. & A. oryzae PDE1 •2. đ”ĆBÞ/(& Ç8 AphA ”Ć1½(& APA4 •ōʃ<1‚GKwµ™Mvm\Nr eF0;(+ AphA BĤ1WwcMá05,Ċċ. &Table 2-3 AphA 1Ċċ. ŌŽ2 4.3 Ō,çŽ2 21.4%,(&Ċċ AphA 1WwcMááƀľ&=1Ŕ ”Ć2 108.4 U/mg ,(& AphA 2 SDS-PAGE ú, 58.0 < 65.0 kDa Fig. 2-3, lane 2 1fv]/bw],(&1ŝÖƀ2ćìWwcMá1EnaÒŋƄ0 *+ªÑ. &ŝÖƀ 47,581 Da ;=8ů 10.0 ~ 17.0 kDa ġħ,(&. AphA 1ŝÖƀ1ªÑħ-âÊ1ħ-1Ä2WwcMá1NsPSt‡0;>8 1,>-º<?>1-2AphA 1ăĴEnaÒŋƄ0 Asn-X-Ser / Thr W Gg1 N ¬¾¦NsPSt‡Śz 7 òFig. 2-2 1Ɇď1EnaÒAsn-104,. 32.

(85) Fig. 2-3. SDS-polyacrylamide gel electrophoresis of AphA purified from an A. oryzae transformant, APA4. AphA was purified as described in the Materials and Methods. The gel was stained with Coomassie Brilliant Blue. The protein band corresponding to the endoglycosidase H is indicated by the arrow. Lane 1, molecular-mass markers: [rabbit muscle phosphorylase b (97.4 kDa), bovine serum albumin (66.3 kDa), rabbit muscle aldolase (42.4 kDa), bovine carbonic anhydrase (30.0 kDa), soybean trypsin inhibitor (20.1 kDa), and egg white lysozyme (14.4 kDa)]; lane 2, purified AphA; lane 3, endogylcosidase H treated AphA.. 33.

(86) Asn-119, Asn-206, Asn-219, Asn-338, Asn-351, Asn-375 ĜË">-5&Jw] NsPSXV H ,Ċċ¼ēBðŻ. & AphA 2Fig. 2-3, lane 3 ŝÖƀ 48.0 kDa. 0õ/(&-08×Û?>Ċċ AphA 1ŝÖƀ2?5,0ŤÀ?& Š1 A. oryzae ¤•,½Ŏ¯?&~ĻÖÐŜ Uchida et al., 2006 -2|/(+& $1}2NsPSt‡1ĵļ1},2/-º<?1-2A. niger 0 A. fumigatus 1eFWVBŎ¯#>ST[o0+NsPSt‡1ĵļ2b ZYŨ0|/>-šÏ?+>-Wyss et al., 1999b <8×Û?> Ċċ AphA 1 N ũEnaÒŋƄ2Gln-Ser-X-Asn-Thr-Val-Asp-Glu-Gly-Tyr-Gln X 2«Ĵřʼn ,(&Fig. 2-2Іď1EnaÒ 1ŋƄ2‡’Ķ0«Ĵ ,/(& Cys-30 Bô Gln-28 < Gln-38 1ăĴEnaÒŋƄ0+˜đ 0Ī. &SignalP 3.0 gvNroBŷ&ŒČ0;=AphA 1 N ũĥ< 19 1E. naÒŋƄ2SN^tSMJwT,>-Ŵĕ?&:0AphA 1 20 < 27 œŭ1EnaÒŋƄ2ĝ1Øþ¤eFWV Wyss et al., 1999a, Lassen et al. 2001 -ŀŶ0gvigY]-ăĴ?&AphA 1 N ũĥEnaÒŋƄ2A. oryzae RIB128 •1 2 )1 Aph ;3 2 )1eFWV-2ġ|/(+&1<AphA 2 A. oryzae RIB128 •0+2ŝŕ?+/81-º<?&.    AphA 1¼ē’ĶĆá Ċċ AphA 0)+1¼ē’ĶĆáBÚ® xĴĆ;3 ļxĴĆBÚ®. &Õ70Ùķ pHÙķ ļpH. &Fig. 2-4Fig. 2-5 AphA 1Ùķ pH 2 4.0Ù. ķ ļ2 40°C ,(&AphA 2 pH3.0 < pH 7.0 1¸ pH Œ{,xĴ,(& AphA 2 ļ 35°C 5,2xĴ,35°C Bį> ļ,¡ě0à”. 34. &.

(87) 100.0. 100.0. 80.0. 80.0. 60.0. 60.0. 40.0. 40.0. 20.0. 20.0. 0.0. 0.0 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 pH. Residual activity (%). 120.0. Relative activity (%). 120.0. Fig. 2-4. Effects of pH on enzyme activity and stability of AphA. The effects of pH on enzyme activity were investigated by measurement at 40°C in various pH acetate buffers. Symbols: , activity;

(88) , stability.. 35.

(89) 120. 100. 100. 80. 80. 60. 60. 40. 40. 20. 20. 0. 0. Residual activity (%). Relative activity (%). 120. 25 30 35 40 45 50 55 60 65 Temperature Fig. 2-5. Effects of temperature on enzyme activity and stability of AphA. The effects of temperature on enzyme activity were investigated by measurement in pH4.0 at various temperatures. For the temperature stability, residual activity was measured at 40°C after incubation in acetate buffer (pH4.0) at various tempereatures. Symbols: , activity;

(90) , stability.. 36.

(91) Table 2-4. Comparison of the properties of AphA with those of other acid phosphatases from A. oryzae AphA. ACP-Ia. ACP-IIa. ACP-IIIa. AphK1b. 58.0 to 65.0. 110. 58. 56. 70. pH optimum. 4.0. 4.5. 5.0. 5.5. 5.5. pH stability. 3.0 to 7.0. 4.3 to 5.5. 4.8 to 6.5. 5.0 to 5.5. 2.0 to 7.0. Optimum temperature (°C). 40. 60. 40. 45. 60. Thermal stability (°C). <35. <45. <35. <40. NDc. Molecular mass (kDa). a. The results of ACP-I, ACP-II and ACP-III were taken from the report by Fujita et al. (Fujita. et al. 2003a). b c. The results of AphK1 were taken from the report by Shimizu (Shimizu 1993).. ND, not determined.. Ý0 AphA 1áŃ|ĆBÚ®. &Table 2-5 á2Ý181BÔŷ. &p-. _\veI_tswÒPNPP eFYwÒphytate α-NsUvswÒ glycerophosphate dvswÒpyrophosphate NtPT 6 swÒ D-glucose-6-phosphate 5' NE_tÒ5’-GMP ;3 5' GaSwÒ5’-IMP ,>AphA 2 PNPP BÇ8ġő„ěļ,ˆĄŝŒ. & . eFYwÒ. phytate α-NsUvswÒglycerophosphate ;3NtPT 6 swÒ D-glucose-6-phosphate 0Ġ. +8 2 ŝ1 1 ĵļ1”ĆBÞ. AphA ¸áŃ. |ĆBű">¼ē,>-Ŭ<0/(&AphA 2 5’-GMP - 5’-IMP 0Ġ +87-8%1ģsw҇”ĆBÞ. &1¬Š;=AphA 2ŪĒ0ň?> 5'-. sk`MuKY]^\sHo1ģsw҇0>ĵļœA(+>‰ʼnĆÞà ?&AphA 2ĝ1 A. oryzae ŲźÒĆjTeDWV-2|/>áŃ|ĆBÛ(+ &1;0 N ũĥEnaÒŋƄ¼ē’ĶĆá;3áŃ|ĆBŔ‘">- 37.

(92) Table 2-5. Comparison of AphA substrate specificity with those of other acid phosphatases from A. oryzae Relative activitya (%) Substrate AphA. ACP-Ib. ACP-IIb. ACP-IIIb. AphK1c. Sodium p-nitrophenylphosphate. 100. 100. 100. 100. 100. Sodium phytate. 54.0. 14. 255. 23. 3.3. Sodium glycerophosphate. 49.2. 10. 0. 81. 93.3. Sodium pyrophosphate. 33.3. NDd. ND. ND. 183.3. D-Glucose-6-phosphate. 43.4. 52. 0. 45. ND. 5’-GMP. 8.1. ND. ND. ND. ND. 5’-IMP. 6.9. ND. ND. ND. ND. a. Hydrolysis rate of p-nitrophenylphosphate was taken as 100%.. b. The results of ACP-I, ACP-II and ACP-III were taken from the report by Fujita et al. (Fujita. et al. 2003a). c. The results of AphK1 were taken from the report by Shimizu (Shimizu 1993).. d. ND, not determined.. AphA 2 Fujita et al Fujita et al., 2003a, 2003b 9 ShimizuShimizu, 1993 ŤÀ &ÒĆjTeDWV9eFWV-2Ŭ0|/(+&5&?2 A. oryzae Ųź1ÒĆjTeDWV 5’-GMP - 5’-IMP <swÒBųż">-BıčĶ0 Þ. &ñ7+1ŤÀ-/(&.   Ÿů ŪĒŷ¿¤ Aspergillus oryzae KBN630 •1½ŘļėŀĔ™©B”ŷ oryzae KBN630 •1ÒĆjTeDWV A ~ĻÖaphA ~ĻÖ BŊŽ 38. +A. &åł.

(93) & aphA ~ĻÖŊŽ•2Ŀ¿,2Ĉü0ĉ€ ”Ć2 A. oryzae KBN630 •-Ŕ‘ WB”ŷ. &. +ů 20%ij†. . ÒĆjTeDWV1. +&¿¤ TEF1 ~ĻÖgvq. + aphA ~ĻÖB½Ŏ¯#&-@AphA WwcMáBōĨĬ0. ŝŕ#>-,&AphA WwcMá1ŝÖƀ2 58.065.0 kDa ,Ùķ pH 2 4.0Ùķ ļ2 40°C ,(&AphA WwcMá2 5’-GMP  3 5’-IMP BŝŒ +ūŸswÒBųż#&. 39.

(94) Ģø ŪĒŷ¿¤1äŸ/ÒĆjTeDWV C ~ĻÖaphC 1ŃĴ- AphC 1óĆá1ŒŬ   ó° Ģø,2A. niger phyA ~ĻÖ-Ç8ėŀĆ1½ A. oryzae KBN630 •Ųź aphA ~ĻÖGenBank accession number AB042805 / AP007157 0)+~ĻÖŊŽ-~ ĻÖ½Ŏ¯0;>ŒČB»(&$1¬ŠaphA ~ĻÖ1P]">ÒĆjTeD WV AphA 25’-IMP ;3 5’-GMP 1ģsw҇”ĆB>ĵļű">- Ŭ<0/(&. . ;(+ 20% ij†. Ŀ¿Ĭ1ÒĆjTeDWV”Ć2aphA ~ĻÖŊŽ0 /(&?<1¬Š<Š1 A. oryzae 1ÒĆjTeD. WVĿ¿Ĭ1ÒĆjTeDWV”Ć0ġžŵ. +>-º<?&. $,Ģø,25’-IMP ģsw҇”ĆBű">äŸ/ÒĆjTeDWVBŬ <0">&70A. niger phyA ~ĻÖ-ėŀĆ1>Ó= 7 ±1¶ţ1 aph ~ĻÖ ŊŽ•BÍí. Ŀ¿Ĭ1¼ēĉÐĆBÚ®. &$1¬ŠaphC ~ĻÖ$. Ŀ¿Ĭ1ÒĆjTeDWV”Ć;3 5’-IMP ģsw҇”Ć1ž”Ć0+ä Ÿ/ٓBŠ&"-ŐŬ. &$,A. oryzae 0+Ç8£Ƃ/gvqW. 1),>WLEnrV~ĻÖtaaG2 ~ĻÖ 1gvqWBŷ+ aphC ~ĻÖB½Ŏ¯#AphC WwcMáBĊċ <0. +$1óĆá;3áŃ|ĆBŬ. &.   â®Ìſ;3⮝Ŧ    Ôŷ¤• ŪĒŷ¿¤• A. oryzae KBN630 •B DNA Įċ0Ôŷ. &Ģø,Íí. & A.. oryzae KBN630 •Ųź1 pyrG, ku70 ~ĻÖńêÎôš|•,> A. oryzae KBN63017K3 •;3ùŰŷ¿¤ KBN616 •Ųź1 alp, pyrG ~ĻÖńêŊŽš|•, > A. oryzae PDE1 B§áĺ™ŷëä-. +Ôŷ. 40. &A. oryzae PDE1 •2Ĕ™W.

(95) wcMáB·Ž;ĉÐ#>&70EtLsgv[EV~ĻÖ alp ~ĻÖ Murakami et al., 1991 BŊŽ. &•,>ŧ•1ÍċťŦ0)+2.Š1. Ÿ‹0Ŏŗ">ŴĴ,>5&Ģø,Íí ÖŊŽ•-. +Ôŷ. & A. oryzae aphA •B aphA ~Ļ. &. E. coli DH5 α Bæ1 DNA ĦŢ1Mv_wN0Ôŷ. &.    ōĨ;3ōŹý­ A. oryzae 1ƒğōŹ02ş,C4CōĨRS ōĨ 3% rice starch1% polypeptone 1% NaNO30.2% KCl0.1% KH2PO40.05% MgSO4.7H2O BÔŷ. + 30°Ců 160 rpm. 1ĺßā-ōŹB»(& Ŀ¿ōŹ2ÿãġĿiuZ\BōŹ-. + 30°C43 ܛ1ōŹB»(&ÿ. ãġĿiuZ\2ġĿBĄ0 2 ܛĂIJ³35 ŝÿ㠟,ı¨ů 10 mmİ 15 ~ 20 mm 0ć§. +Ôŷ. +,&ÿãġĿBnwY. &. E.coli 1ōŹ02 2xYT ōĨ1.6% Bacto tryptone1.0% Bacto yeast extract0.5% NaCl BŷŖŸ0„!+ňļ 50μg/mL 1 ampicillin sodium Bň Agar Bň. ²ğōŹÜ02 1.5%. &ōŹ2 37°C 0+»(&.    A. oryzae 1§áĺ™ A. oryzaepyrG B MPU ōĨ2.0% malt extract0.1% Bacto peptone2.0% glucose 0.25% uridinepH6.5 Ĭ, 30 24 ܛōʳ  0Þ. &ťŦ-ŀŶ0. Novozyme234 ;3 Cellulase “ONOZUKA” R-10 Bŷ+gv\grT\‡. &ł. <?&gv\grT\0 PEG Ĝˆ, DNA ĦŢ1å=Á6B»A#+§áĺ™B» Æĉ—ĸōĨĬ, 30°Cůè›ōŹ. +§á噕Båł. &.    A. oryzae ĎĀğ DNA 1ĮċPCR ;3 DNA SMJwT. 41.

(96) A. oryzae 1ĎĀğ DNA 2GP ōĨ, 30°C3 Ņ›ōŹ é¤. +ĄŝBô¢. &³Ľ¬–Ė. +ŞÈ. & A. oryzae 1¤ğB. eIat-MvvjtoŦ,Į. &Sambrook and Russell, 2001; Raeder and Bronda, 1985 . ċ. PCR ŷ¼ē2TaKaRa Ex Taq DNA lsprVTakara Bio, Otsu, Shiga ;3 PfuUltra II Fusion HS DNA polymeraseStratagene, La Jolla, CA, USA BÔŷ. $?. %?1gv\Pt0ï!+ő„B»(&PCR Ęĩ2 GeneAmp9700 RmtRGM rApplied Biosystems, Foster City, CA, USA BÔŷ Q`MuKY]grGmB Table 3-1 0Þ. &Ģø,Ôŷ. &Ks. &. ä/Mv_wNT[Zg,2model 4000LS DNA SOwRLI-COR, Lincoln, NE, USA ;3 GenomeLab GeXPBeckman Coulter, Brea, CA, USA Bŷ&S MJwSwN0;=ĉćŜBŇ. &.    aph ~ĻÖ¥1ŊŽŷhMW1¹ī aphB ~ĻÖŊŽŷhMWpDisAphB By†1;0¹ī. &aphB ~ĻÖ1. 5’-ƃčƁ 1.0-kb - 3’-ƃčƁ 1.0-kb B$?%? A. oryzae ĎĀğ DNA -grG miE phyB1/phyB2 ;3 phyB3/phyB4 Bŷ+ PCR ęś. &pyrG ~ĻÖĦŢ. 1.8-kb B A. oryzae ĎĀğ DNA -grGmiE pyrGN2/ pyrGC2Table 1-1 Bŷ + PCR ęś. &ł<?& 3 )1 PCR ęśĦŢ- SmaI ,ö‡. 1¾ª 4 ĦŢB¾. In-Fusion Advantage PCR Cloning KitTakara Bio Bŷ+. In-Fusion ő„B»(&1;0. +ł<?&aphB ~ĻÖ1 5’-ƃčƁ- 3’-. ƃčƁ1›0 pyrG ~ĻÖzĩ">grTn]B pDisAphB pDisAphB B[wgu\-. &grTn]. grGmiE phyB1/phyB4 Bŷ& PCR 0;=. aphB ~ĻÖŊŽŷ DNA ĦŢBęś. A. oryzae KBN630-17K3 B§áĺ™. aphB ~ĻÖŊŽ1ŇÚ®02§áĺ™ğ<ĭí \-. &hMWpUC18. &. &ĎĀğ DNA B[wgu. +ŷgrGmiE phyB1/phyB4 Bŷ& PCR B»(&Table 1 1gr. 42.

(97) Table 3-1. Oligonucleotide primers used in Chapter 3 Name. Sequence (5’ to 3’). Direction. Primers for gene disruption The aphB gene phyB1. CGGTACCCGGGGATCCCAACCGTACTCCTAGGAGTGG. Forward. phyB2. TTCCAGCAGGCCTTGAAAGCATGGCGCACTATCGCGG. Reverse. phyB3. ATTGATCAGGCCTTTCGACCAGCTAACCAAGACTAGT. Forward. phyB4. ATGCCTGCAGGTCGACATGATCAACGAATTCCTTCAACG. Reverse. The aphC gene phyC1. CGGTACCCGGGGATCCTATGCCGGGATACTAACACAAT. Forward. phyC2. TTCCAGCAGGCCTTGCTATTAGTGGGTAATGCATAGTG. Reverse. phyC3. ATTGATCAGGCCTTTGAATGAGTGGGAGTATGTGCTC. Forward. phyC4. ATGCCTGCAGGTCGACAAGTCCAGATCTCGGAAATCAG. Reverse. The aphD gene phyD1. CGGTACCCGGGGATCCATCCTTAACAGTAGACTACTTGG. Forward. phyD2. TTCCAGCAGGCCTTGCAGACTAACACTTCTAGACTAAG. Reverse. phyD3. ATTGATCAGGCCTTTAACTTCCGAACCCGCTATGCTAG. Forward. phyD4. ATGCCTGCAGGTCGACAACTTGACTCTCGTTCTTCGGTG. Reverse. The aphE gene phyE1. CGGTACCCGGGGATCCCTGTGATCACTTTGAATAACACC. Forward. phyE2. TTCCAGCAGGCCTTGCAACATAACTTACTTGAAGACCAG. Reverse. phyE3. ATTGATCAGGCCTTTGGTCGTGATATTTTGCTTGCCAC. Forward. phyE4. ATGCCTGCAGGTCGACAGGTCCAGATTTCGGAGATTAG. Reverse. 43.

(98) The aphF gene phyF1. CGGTACCCGGGGATCCAGAATACAACATGCTGACTATGG. Forward. phyF2. TTCCAGCAGGCCTTGATGCGATACTAAGCAAAGCAATC. Reverse. phyF3. ATTGATCAGGCCTTTGCTCAAAGGGTCACTTGATCGCC. Forward. phyF4. ATGCCTGCAGGTCGACATACTAGATGGAACCGGAAAGG. Reverse. The aphG gene phyG1. CGGTACCCGGGGATCCTTTAGACAATTTCAGTCCCGCTC. Forward. phyG2. TTCCAGCAGGCCTTGAAATGCAGCAGGTACGTTCTC. Reverse. phyG3. ATTGATCAGGCCTTTGGATCAAATACGGCAGGCTG. Forward. phyG4. ATGCCTGCAGGTCGACATAGAGGATCGGATCCAAAGAG. Reverse. The aphH gene phyH1. CGGTACCCGGGGATCCACACAGAACAAACAAAAGATCTG. Forward. phyH2. TTCCAGCAGGCCTTGGTGAAGTTCTCTAGACTCTAGG. Reverse. phyH3. ATTGATCAGGCCTTTCCTTAATGACTGGAGCTATGGGC. Forward. phyH4. ATGCCTGCAGGTCGACCTTCATGAACGTGTCAAGCTCAC. Reverse. Primers for aphC expression vector fupyrGN CGGTACCCGGGGATCCAAGCCGCTGCTGGAATTGACA. Forward. pyrGC3 TCAGAAGAAAAGGATGATCAATACC. Reverse. pyrGtaa ATCCTTTTCTTCTGAATTCATGGTGTTTTGATCATTTT. Forward. taaPrev CATAAATGCCTTCTGTGGGGTTTATTGTT. Reverse. taaaphC CAGAAGGCATTTATGCAGCAATTATTGCAATCAACGG. Forward. aphCSal ATGCCTGCAGGTCGACGGGTTGATAGAGCTTGTTCTGGTGATC Reverse. 44.

(99) GmiEBÔŷ. +$1ĝ1 6 ±1 aph ~ĻÖŊŽhMWpDisAphC <. pDisAphH 5,B pDisAphB -ŀŶ1ťŦ,¹ī. &6 ±1 aph ~ĻÖŊŽŷ DNA. ĦŢ0)+8 aphB ~ĻÖ1û¾-ŀŶ0ęś. A. oryzae KBN630-17K3 0Łņ. &~ĻÖŊŽ1ŇÚ®02§áĺ™ğ<ĭí \-. &ĎĀğ DNA B[wgu. +ŷ aph ~ĻÖ0Ń|Ķ/grGmiEaphC ~ĻÖ0)+2. phyC1/phyC4aphD ~ĻÖ0)+2 phyD1/phyD4aphE ~ĻÖ0)+2 phyE1/phyE4aphF ~ĻÖ0)+2 phyF1/phyF4aphG ~ĻÖ0)+2 phyG1/phyG4aphH ~ĻÖ0)+2 phyH1/phyH BÔŷ. + PCR B»(&.    A. oryzae taaG2 ~ĻÖgvqW1ą´†0> aphC ~ĻÖ1Ŏ ¯ aphC ~ĻÖB A. oryzae taaG2 ~ĻÖgvqWTsukagoshi et al., 1989 1ą´ †,Ŏ¯#>&70aphC ~ĻÖ½Ŏ¯ŷhMWpTAAphC By†1;0¹ ī. &pyrG ~ĻÖĦŢ 1.8-kb B A. oryzae KBN630 •1ĎĀğ DNA -grGm. iE fupyrGN/pyrGC3 Bŷ+ PCR ęś &A. oryzae taaG2 ~ĻÖ1gvqW 0.6-kb ĦŢB A. oryzae ĎĀğ DNA -grGmiE pyrGtaa/taaPrev Bŷ+ęś &aphC ~ĻÖ 2.0-kb ĦŢB A. oryzae ĎĀğ DNA -grGmiE taaaphC/aphCSal Bŷ+ęś. &ł<?& 3 )1 PCR ęśĦŢ-BamHI/SalI ,ö. &hMWpUC18 1¾ª 4 ĦŢB¾. In-Fusion Advantage PCR Cloning Kit B. ŷ+ In-Fusion ő„B»(&1;0. +ł<?&taaG2 ~ĻÖ1gvqW. ‡.  aphC ~ĻÖ1P]Ɓ1ƃ0Ĉ0zĩ">grTn]B pTAAphC $. +grTn] pTAAphC B A. oryzae PDE1 •0Łņ. &. &. aphC ~ĻÖ1Gw\vwBŇ">&70High Fidelity RNA PCR KitTakara Bio -³î1 AphC ½ĉЕ<ł<?&\Wt RNA Bŷ+ RT-PCR B»(&ń ŧÅ cDNA ¾ć2 Adaptor Primer FB - taaaphC 1grGmiEBŷ+»(&. 45.

(100) 0' HincII $Éx. èěõĠ9ID?iJ5. pUC118 'DhUiE. .

(101) A. oryzae ªÛ³ 3( AphC LiXD»(ÜÝ;`V´đĺ—ā 2*ðEfGIgx –»ą‡ ( A. oryzae APC15 9 RS Ēö$ 5 ψĒı ‘. ”ë97|#È. žĒıÌÚ 50 ml 9 10 mM Tris-HCl bufferpH 7.0$ĉÞ. (ä©å. HR16/20 Fast Flow Q-Sepharose q<AiŸ‡Bea. t9ĊWOZ:$Шx. '(0.0 M 3 0.25 M NaCl (þá£đ'24ĮÃ. AphC 9‰/ĝ~9ĊW. OZ:'ì#ĉÞ¯ć HR16/20 Fast Flow Q-Sepharose q<AiŸ‡Bea' (Ċϙ$¯ćĮÃ.  AphC 9‰/ĝ~9ĊWOZ:'ì#ĉÞ. ž 40% ģĻ%&52'Ķj9z $Шx. 1(940% ģĻĶj9z. ĊWOZ:. HiLoad 26/10 Phenyl Sepharose HPGE HealthcareBea'’. B. ea9ШxWOZ:$=@OIcúLiXD»9 40% 3 0% ģĻĶj (þá£đ'24ĮÃ. AphC 9‰/ĝ~9 10 mM Tris-HCl bufferpH 7.0$ĉ. ÞSDS-PAGE $ñpWiS'&5%9‚ď 5. N Ħô;`V´đĺ9Þ. 0'ÜÝ©å9 ProSorbApplied Biosystemsçø9į# PVDF ĥ'ą½. Applied Biosystems Procise 491 ID?iH9į#ßĨÇApplied Biosystems 'Âđĺ9—ā. ÜÝ©å(ðEfGIgx) endoglycosidase HGlyko, Novato,. CA, USA9į#bBßĨÇ'Â!#§! 'LiXD»(ğ×9§!. endoglycosidase H 9Ąz5ã. .

(102)  ©å„×(éā ´×^JZ:LK„×)î÷3Oike et al., 1984(ġĢ9¾†ğ¤#§! pāķ(©åt9 100 mM Ô´WOZ:pH 4.0'Į Ugfi´PNPPĮtû$ 40°C 10 ĝ<iCc\R. 46. . 1 mM p-URhZ>. ©åēu9 10% Rf.

(103) DhhÔ´Įt9z#Ā·. 2 M ó´TRf=aĮt9z. p-URhZ>VgPNPķ9 405 nm ( ć'24éā Ĥϙ$ 1 ĝˆ' 1 mol ( PNP 9ĪIJ5©åķ%. žĪIJ. ©å dUOR). Ĉ¬Ēı(Í«)´×. ^JZ:LK„×éā(ēuϙ) 40°C10 ĝ'í#37°C20 ĝ%. . ©å(¸ă pH )ĭ& pH3.0 to 7.0( 100 mM Ô´TRf=apH 4.0Į tû$©å9 40°C10 ĝ<iCc\R#éā. ©å(¸ăvć)100 mM. Ô´TRf=aĮtû$©å9ĭ&vć25°C to 65°C$ 10 ĝ<iCc\R #éā c\R. vćjā×% pH jā×)ĭ&vć25°C to 65°C$ 30 ĝ<iC ž%ĭ& pH3.0 to 7.0$ 30°C1 ¹ˆ<iCc\R. ž(. 100 mM Ô´WO. ©å„×966éā. Š»ċm×)kw(2'ý+. Z:pH 4.0'Į. 2 mM (Š»Įtû$©å9 40°C30 ĝ<iCc\. R. ĪIJ. 9į#éā. ħ‹fi´ķ9 Phosphor C Test KitWako Pure Chemical, Osaka, Japan . ;gZ:;`eK„×)¡āĢNishiya, 1993'Â!#éā ;K„×)¡āĢNishiya 19939¾†ğ¤#éā. WOZ:) McIlvaine. bufferpH 3.0'í# McIlvaine bufferpH 6.09µį 5’-IMP (ðfi´„×)kw(2'§!. . 1 mL ( 20 mM IMP Įt9 0.2 mL. ( 200 mM Ô´WOZ:pH 4.0%­«0.1 mL (ĉÞ 37°C $ 20 ĝ<iCc\R. û×[hP. Ēıt9z#. ēu9 0.1 mL ( 1 N NaOH Įt9z#Ā·. 0.1 mL ( 1 N HCl Įt9z#ûĻ. ĪIJ. fi´9 Pi ColorLock ALS. Innova Biosciences Ltd., Cambridge, UK9į#éā. ©å„×(āŽ)Ĥ. éāϙw$ 1 ĝˆ' 1 μmol (fi´9ĪIJ5©åķ9 1 dUOR%. .

(104)  GiYcL'25đĺÞ aph nƶ(æĊך±)ČĴ§ØĢÓÝĘėyÄŠĔ‹¥NITE( the. 47.

Fig. I-2. A hypothetical primary pathway for degradation of 5’-IMP (5’-nucleotides)  added to unheated miso
Table 1-1.  Selective marker genes used for  Aspergillus oryzae transformation
Fig. 1-1. Intergation machinery of exogenous DNA into chromosome.
Fig. 1-2. Uracil biosynthesis pathway
+7

参照

Outline

関連したドキュメント

その産生はアルドステロン合成酵素(酵素遺伝 子CYP11B2)により調節されている.CYP11B2

第4章では,第3章で述べたαおよび6位に不斉中心を持つ13-メトキシアシルシランに

今日のお話の本題, 「マウスの遺伝子を操作する」です。まず,外から遺伝子を入れると

2001 年初上場以来、様々な種類の J-REIT

分子インプリント薄膜のゲート効果に関する基礎研究 Basic research of gate effect on

Isolated [(p-cymene)RuOTf(DppBz)]OTf showed good catalytic activity for the addition reaction of N-methyltosylamide, 4-ethylbenzoic acid, and 2-phenylethanol onto styrene in CHCl 3

ガーリックライス・香の物・味噌椀 / ZENB 冷麺 Garlic Rice, Pickled Vegetables, Miso Soup/ Cold “ZENB” Noodles.

そこで本研究では, 都市下水処理UASB 槽内に生息する嫌気 性原生動物 Metopus sp.体内の共生微生物叢を明らかにする ため, 16S rRNA 遺伝子に基づく遺伝子解析及び